Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

Articles published in
Clin Breast Cancer
    June 2021
  1. LIU X, Liu M, Ma H, Wang J, et al
    miR-875 Serves as A Candidate Biomarker for Detection and Prognosis and Is Correlated with PHH3 Index Levels in Breast Cancer Patients.
    Clin Breast Cancer. 2021 Jun 23. pii: S1526-8209(21)00169.
    >> Share

  2. LU JF, Hu ZQ, Yang MX, Liu WY, et al
    Downregulation of PDGF-D Inhibits Proliferation and Invasion in Breast Cancer MDA-MB-231 Cells.
    Clin Breast Cancer. 2021 Jun 23. pii: S1526-8209(21)00147.
    >> Share

  3. SEKI H, Higeta K, Sakurai T, Sakurada A, et al
    Feasibility Study of Nanoparticle Albumin-Bound-Paclitaxel and S-1 Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With Operable Breast Cancer: A Prospective Study.
    Clin Breast Cancer. 2021 Jun 18. pii: S1526-8209(21)00152.
    >> Share

  4. SHENOUDA M, Copley R, Pacioles T, Lebowicz Y, et al
    Effect of Tart Cherry on Aromatase Inhibitor-Induced Arthralgia (AIA) in Nonmetastatic Hormone-Positive Breast Cancer Patients: A Randomized Double-Blind Placebo-Controlled Trial.
    Clin Breast Cancer. 2021 Jun 18. pii: S1526-8209(21)00151.
    >> Share

  5. CHEN M, Wu J, Liu D, Chen W, et al
    Combined Estrogen Receptor and Progesterone Receptor Level Can Predict Survival Outcome in Human Epidermal Growth Factor Receptor 2-positive Early Breast Cancer.
    Clin Breast Cancer. 2021 Jun 16. pii: S1526-8209(21)00140.
    >> Share

  6. TOKUI R, Ishitobi M, Kurita T, Hatano T, et al
    A Comparison of the Oncological Outcomes After Breast-Conserving Surgery With or Without Latissimus Dorsi Myocutaneous Flap Reconstruction for Breast Cancer.
    Clin Breast Cancer. 2021 Jun 15. pii: S1526-8209(21)00150.
    >> Share

  7. DONG L, Lin S, Zhong L, Nian D, et al
    Evaluation of Tucatinib in HER2-Positive Breast Cancer Patients With Brain Metastases: A United States-Based Cost-Effectiveness Analysis.
    Clin Breast Cancer. 2021 Jun 12. pii: S1526-8209(21)00146.
    >> Share

  8. SCHLAFSTEIN A, Liu Y, Goyal S, Kahn S, et al
    Regional Nodal Irradiation for Clinically Node-Positive Breast Cancer Patients With Pathologic Negative Nodes After Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2021 Jun 12. pii: S1526-8209(21)00148.
    >> Share

  9. OCCHIOGROSSO RH, Ren S, Tayob N, Li T, et al
    Feasibility of an Online Patient Community to Support Older Women With Newly Diagnosed Breast Cancer.
    Clin Breast Cancer. 2021 Jun 12. pii: S1526-8209(21)00149.
    >> Share

  10. FALCONE V, Reiser E, Grula L, Bago-Horvath Z, et al
    Correlation Between Preoperative Radiological and Postoperative Pathological Tumor Size in Patients With HER2(+) Breast Cancer After Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab.
    Clin Breast Cancer. 2021 Jun 10. pii: S1526-8209(21)00145.
    >> Share

  11. MO H, Jazieh KA, Brinzevich D, Abraham J, et al
    A Review of Treatment-Induced Pulmonary Toxicity in Breast Cancer.
    Clin Breast Cancer. 2021 Jun 10. pii: S1526-8209(21)00142.
    >> Share

  12. CERNUSCO NLV, Bianco PD, Romano M, Muraglia A, et al
    Long-Term Outcomes Using Electron IOERT APBI for Early Stage Breast Cancer: The Verona University Hospital Experience.
    Clin Breast Cancer. 2021 Jun 10. pii: S1526-8209(21)00143.
    >> Share

  13. BORTOLOZO HI, Derchain S, Vechin FC, Maginador GF, et al
    Aerobic Fitness is a Predictor of Body Composition in Women With Breast Cancer at Diagnosis.
    Clin Breast Cancer. 2021;21:e245-e251.
    >> Share

  14. ANAND K, Niravath P, Patel T, Ensor J, et al
    A Phase II Study of the Efficacy and Safety of Chloroquine in Combination With Taxanes in the Treatment of Patients With Advanced or Metastatic Anthracycline-refractory Breast Cancer.
    Clin Breast Cancer. 2021;21:199-204.
    >> Share

    May 2021
  15. HATZIPANAGIOTOU ME, Huber D, Gerthofer V, Hetterich M, et al
    Feasibility of ABUS as an Alternative to Handheld Ultrasound for Response Control in Neoadjuvant Breast Cancer Treatment.
    Clin Breast Cancer. 2021 May 26. pii: S1526-8209(21)00138.
    >> Share

  16. SYMONDS L, Jenkins I, Linden HM, Kurland B, et al
    A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Ca
    Clin Breast Cancer. 2021 May 24. pii: S1526-8209(21)00137.
    >> Share

  17. MEYER C, Bailleux C, Chamorey E, Schiappa R, et al
    Factors Involved in Delaying Initiation of Adjuvant Chemotherapy After Breast Cancer Surgery.
    Clin Breast Cancer. 2021 May 24. pii: S1526-8209(21)00135.
    >> Share

  18. HE X, Dai X, Ji J, Liu H, et al
    Nine-Year Median Follow-up of Ccardiotoxicity and Efficacy of Trastuzumab Concurrently With Anthracycline-Based and Anthracycline-Free Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer Patients.
    Clin Breast Cancer. 2021 May 24. pii: S1526-8209(21)00136.
    >> Share

  19. DENG C, Xie Y, Liu Y, Li Y, et al
    Aromatherapy Plus Music Therapy Improve Pain Intensity and Anxiety Scores in Patients With Breast Cancer During Perioperative Periods: A Randomized Controlled Trial.
    Clin Breast Cancer. 2021 May 20. pii: S1526-8209(21)00134.
    >> Share

  20. WANG M, Liu H, Wu W, Zhao J, et al
    Identification of Differentially Expressed Plasma lncRNAs As Potential Biomarkers for Breast Cancer.
    Clin Breast Cancer. 2021 May 18. pii: S1526-8209(21)00131.
    >> Share

  21. MEMON R, Prieto Granada CN, Harada S, Winokur T, et al
    Discordance Between Immunohistochemistry and In Situ Hybridization to Detect HER2 Overexpression/Gene Amplification in Breast Cancer in the Modern Age: A Single Institution Experience and Pooled Literature Review Study: Discordance between HER2 overex
    Clin Breast Cancer. 2021 May 17. pii: S1526-8209(21)00132.
    >> Share

  22. GUILLERM SO, Bourstyn E, Itti R, Cahen-Doidy L, et al
    Intraoperative Radiotherapy for Breast Cancer in Elderly Women.
    Clin Breast Cancer. 2021 May 15. pii: S1526-8209(21)00130.
    >> Share

  23. HAMILTON EP, Kaklamani V, Falkson C, Vidal GA, et al
    Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study.
    Clin Breast Cancer. 2021 May 15. pii: S1526-8209(21)00089.
    >> Share

  24. ZHOU J, Liu Y, Xu M, Mei L, et al
    Management of Breast Cancer Patients During the Coronavirus Disease 2019 Pandemic: The Experience From the Epicenter of China, Wuhan.
    Clin Breast Cancer. 2021 May 6. pii: S1526-8209(21)00114.
    >> Share

  25. JI X, Li D, Gao D, Lv X, et al
    Value of Ultrasound-Guided Biopsy in Evaluating Internal Mammary Lymph Node Metastases in Breast Cancer.
    Clin Breast Cancer. 2021 May 6. pii: S1526-8209(21)00116.
    >> Share

  26. TJOE JA, Heslin K, Perez Moreno AC, Thomas S, et al
    Factors Associated With Breast Cancer Surgery Delay Within a Coordinated Multihospital Community Health System: When Does Surgical Delay Impact Outcome?
    Clin Breast Cancer. 2021 May 3. pii: S1526-8209(21)00090.
    >> Share

    April 2021
  27. JIA L, Ling Y, Li K, Zhang L, et al
    A 10-Gene Signature for Predicting the Response to Neoadjuvant Trastuzumab Therapy in HER2-Positive Breast Cancer.
    Clin Breast Cancer. 2021 Apr 29. pii: S1526-8209(21)00088.
    >> Share

  28. SHAPIRO CL
    Bone-modifying Agents (BMAs) in Breast Cancer.
    Clin Breast Cancer. 2021 Apr 26. pii: S1526-8209(21)00087.
    >> Share

  29. SHEIKHHOSSEIN F, Shab-Bidar S, Amini MR, Hosseini F, et al
    Dietary Insulin Index and Insulin Load in Relation to Breast Cancer: Findings from a Case-Control Study.
    Clin Breast Cancer. 2021 Apr 24. pii: S1526-8209(21)00086.
    >> Share

  30. LEE Y, Kang E, Shin HC, Lee H, et al
    The Effect of Body Mass Index on Initial Breast Cancer Stage Among Korean Women.
    Clin Breast Cancer. 2021 Apr 22. pii: S1526-8209(21)00085.
    >> Share

  31. WERUTSKY G, Reinert T, Rosa ML, Barrios CH, et al
    Real-world Data on First-line Systemic Therapy for Hormone Receptor-positive HER2-negative Metastatic Breast Cancer: A Trend Shift in the Era of CDK 4/6 Inhibitors.
    Clin Breast Cancer. 2021 Apr 20. pii: S1526-8209(21)00071.
    >> Share

  32. VILLARREAL-GARZA C, Ferrigno AS, Mesa-Chavez F, Platas A, et al
    Improving Collection of Real-World Data: The Experience of the Joven & Fuerte Prospective Cohort for Mexican Young Women With Breast Cancer.
    Clin Breast Cancer. 2021 Apr 20. pii: S1526-8209(21)00083.
    >> Share

  33. PANG J, Zhou H, Dong X, Wang S, et al
    Relationship Between the Neutrophil to Lymphocyte Ratio, Stromal Tumor-infiltrating Lymphocytes, and the Prognosis and Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer.
    Clin Breast Cancer. 2021 Apr 14. pii: S1526-8209(21)00072.
    >> Share

  34. ECE SOLMAZ A, Yeniay L, Gokmen E, Zekioglu O, et al
    Clinical Contribution of Next-Generation Sequencing Multigene Panel Testing for BRCA Negative High-Risk Patients With Breast Cancer.
    Clin Breast Cancer. 2021 Apr 12. pii: S1526-8209(21)00070.
    >> Share

  35. LI X, Yan C, Xiao J, Xu X, et al
    Factors Associated With Surgical Modality Following Neoadjuvant Chemotherapy in Patients with Breast Cancer.
    Clin Breast Cancer. 2021 Apr 8. pii: S1526-8209(21)00066.
    >> Share

  36. ARIF KMT, Bradshaw G, Nguyen TTN, Smith RA, et al
    Genetic Association Analysis Implicates Six MicroRNA-Related SNPs With Increased Risk of Breast Cancer in Australian Caucasian Women.
    Clin Breast Cancer. 2021 Apr 5. pii: S1526-8209(21)00067.
    >> Share

  37. SILVA FR, Grande AJ, Lacerda Macedo AC, Colonetti T, et al
    Meta-Analysis of Breast Cancer Risk in Levonorgestrel-Releasing Intrauterine System Users.
    Clin Breast Cancer. 2021 Apr 3. pii: S1526-8209(21)00068.
    >> Share

  38. WITT JS, Wisinski KB, Anderson BM
    Concurrent Radiation and Modern Systemic Therapies for Breast Cancer: An Ever-Expanding Frontier.
    Clin Breast Cancer. 2021;21:120-127.
    >> Share

  39. CASEY DL, Gupta GP, Ollila DW
    The Role of Intraoperative Radiation in Early-stage Breast Cancer.
    Clin Breast Cancer. 2021;21:103-111.
    >> Share

    March 2021
  40. REINERT T, de Souza ABA, Rosa ML, Bedin SR, et al
    Perspectives on the Systemic Staging in Newly Diagnosed Breast Cancer.
    Clin Breast Cancer. 2021 Mar 27. pii: S1526-8209(21)00065.
    >> Share

  41. MCEVOY MP, Ravetch E, Patel G, Fox J, et al
    Prevention of Breast Cancer-Related Lymphedema.
    Clin Breast Cancer. 2021 Mar 17. pii: S1526-8209(21)00051.
    >> Share

  42. NGUYEN AT, Shiao SL, McArthur HL
    Advances in Combining Radiation and Immunotherapy in Breast Cancer.
    Clin Breast Cancer. 2021 Mar 16. pii: S1526-8209(21)00062.
    >> Share

  43. HALEY B, Batra K, Sahoo S, Froehlich T, et al
    A Phase I/Ib Trial of PD 0332991 (Palbociclib) and T-DM1 in HER2-Positive Advanced Breast Cancer After Trastuzumab and Taxane Therapy.
    Clin Breast Cancer. 2021 Mar 11. pii: S1526-8209(21)00060.
    >> Share

  44. JOY AA, Vos LJ, Pituskin E, Cook SF, et al
    Uridine Glucuronosyltransferase 2B7 Polymorphism-Based Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy for Early-Stage Breast Cancer.
    Clin Breast Cancer. 2021 Mar 6. pii: S1526-8209(21)00056.
    >> Share

  45. LEE E, Tweed C, Mylander C, Martino L, et al
    The Impact of Genomic Profiling on Adjuvant Therapy Recommendation in Postmenopausal Women with ER-Positive, T1-2 Breast Cancer: Can Genomic Profiling Eliminate the Need for Sentinel Lymph Node Biopsy?
    Clin Breast Cancer. 2021 Mar 4. pii: S1526-8209(21)00053.
    >> Share

    February 2021
  46. KOZAK MM, von Eyben R, Gutkin PM, Vemuri M, et al
    Locoregional and Distant Outcomes in Women With cT1-3N1 Breast Cancer Treated With Neoadjuvant Chemotherapy With or Without Adjuvant Radiotherapy.
    Clin Breast Cancer. 2021 Feb 26. pii: S1526-8209(21)00050.
    >> Share

  47. SALVATORE S, Nappi RE, Casiraghi A, Ruffolo AF, et al
    Microablative Fractional CO2 Laser for Vulvovaginal Atrophy in Women With a History of Breast Cancer: A Pilot Study at 4-week Follow-up.
    Clin Breast Cancer. 2021 Feb 23. pii: S1526-8209(21)00007.
    >> Share

  48. GURU SD, Hoskin TL, Whaley DH, Nathan MA, et al
    Repeat Sentinel Lymph Node Surgery in Recurrent Breast Cancer: Peritumoral vs. Periareolar Injections.
    Clin Breast Cancer. 2021 Feb 18. pii: S1526-8209(21)00046.
    >> Share

  49. LEE SJ, Lee J, Jung JH, Park HY, et al
    Exosomal Del-1 as a Potent Diagnostic Marker for Breast Cancer: Prospective Cohort Study.
    Clin Breast Cancer. 2021 Feb 17. pii: S1526-8209(21)00044.
    >> Share

  50. MA S, Guo C, Sun C, Han T, et al
    Aspirin Use and Risk of Breast Cancer: A Meta-analysis of Observational Studies from 1989 to 2019.
    Clin Breast Cancer. 2021 Feb 17. pii: S1526-8209(21)00047.
    >> Share

  51. BOUZIDI L, Triki H, Charfi S, Kridis WB, et al
    Prognostic Value of Natural Killer Cells Besides Tumor-Infiltrating Lymphocytes in Breast Cancer Tissues.
    Clin Breast Cancer. 2021 Feb 16. pii: S1526-8209(21)00045.
    >> Share

  52. JACKISCH C, Barcenas CH, Bartsch R, Palma JD, et al
    Optimal Strategies for Successful Initiation of Neratinib in Patients with HER2-Positive Breast Cancer.
    Clin Breast Cancer. 2021 Feb 6. pii: S1526-8209(21)00043.
    >> Share

  53. HUANG X, Lin S, Rao X, Zeng D, et al
    First-line Treatment with Ribociclib plus Endocrine Therapy for Premenopausal Women with Hormone-receptor-positive Advanced Breast Cancer: A Cost-effectiveness Analysis.
    Clin Breast Cancer. 2021 Feb 4. pii: S1526-8209(21)00041.
    >> Share

  54. TESFAW A, Getachew S, Addissie A, Jemal A, et al
    Late-Stage Diagnosis and Associated Factors Among Breast Cancer Patients in South and Southwest Ethiopia: A Multicenter Study.
    Clin Breast Cancer. 2021;21:e112-e119.
    >> Share

  55. SEFIDBAKHT S, Askarian M, Bijan B, Eghtedari M, et al
    Resuming Breast Imaging Services in the Aftermath of the COVID-19 Pandemic: Safety and Beyond.
    Clin Breast Cancer. 2021;21:e136-e140.
    >> Share

  56. TAKASHIMA T, Hara F, Iwamoto T, Uemura Y, et al
    A Correlation Analysis Between Metabolism-related Genes and Treatment Response to S-1 as First-line Chemotherapy for Metastatic Breast Cancer: The SELECT BC-EURECA Study.
    Clin Breast Cancer. 2021 Feb 1. pii: S1526-8209(21)00040.
    >> Share

  57. CAZZANIGA ME, Giordano M, Bandera M, Cassani C, et al
    Managing Menopausal Symptoms in Young Women With Breast Cancer: When Medicine Is Not All. The Take Care Project.
    Clin Breast Cancer. 2021 Feb 1. pii: S1526-8209(21)00022.
    >> Share

    January 2021
  58. DAILY K, Douglas E, Romitti PA, Thomas A, et al
    Epidemiology of De Novo Metastatic Breast Cancer.
    Clin Breast Cancer. 2021 Jan 31. pii: S1526-8209(21)00029.
    >> Share

  59. AGGARWAL A, Adepoju B, Yacur M, Maron D, et al
    Gender Disparity in Breast Cancer: A Veteran Population-Based Comparison.
    Clin Breast Cancer. 2021 Jan 26. pii: S1526-8209(21)00026.
    >> Share

  60. WU J, Zhou Z
    MicroRNA-432 Acts as a Prognostic Biomarker and an Inhibitor of Cell Proliferation, Migration, and Invasion in Breast Cancer.
    Clin Breast Cancer. 2021 Jan 23. pii: S1526-8209(21)00025.
    >> Share

  61. ANOOP TM, Joseph P R, Pn M, Kp P, et al
    Cutaneous Toxicities in Breast Cancer Patients Receiving Chemotherapy and Targeted Agents--An Observational Clinical Study.
    Clin Breast Cancer. 2021 Jan 23. pii: S1526-8209(21)00021.
    >> Share

  62. LIN J, Guo Z, Wang S, Zheng X, et al
    Omission of Chemotherapy in HR+/HER2- Early Invasive Breast Cancer Based on Combined 6-IHC Score?
    Clin Breast Cancer. 2021 Jan 23. pii: S1526-8209(21)00023.
    >> Share

  63. SHARMA RD, Sharmin A, Sinha A, Solomon A, et al
    Is it Possible to Predict Non Sentinel Node Positivity on the Basis of mRNA Copy Numbers of CK19 Receptor in Breast Cancer?
    Clin Breast Cancer. 2021 Jan 23. pii: S1526-8209(21)00024.
    >> Share

  64. WEI G, Kumar A, Lee MC, Wang X, et al
    Influential Factors on Risk-reduction Mastectomy in a High-risk Breast Cancer Population With Genetic Predispositions.
    Clin Breast Cancer. 2021 Jan 19. pii: S1526-8209(21)00020.
    >> Share

  65. LAILLER G, Memoli V, Le Bihan Benjamin C, Ben Diane MK, et al
    Five-Year Adjuvant Endocrine Therapy Adherence Trajectories Among Women With Breast Cancer: A Nationwide French Study Using Administrative Data.
    Clin Breast Cancer. 2021 Jan 13. pii: S1526-8209(21)00019.
    >> Share

  66. MARTIN HUERTAS R, Fernandez Abad M, Corral de la Fuente E, Serrano Domingo JJ, et al
    Prolonged Responses With Trastuzumab Emtasine Treatment of Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer Refractory to Trastuzumab and Pertuzumab: Systematic Review of Evidence.
    Clin Breast Cancer. 2021 Jan 7. pii: S1526-8209(21)00005.
    >> Share

  67. PADMALATHA S, Tsai YT, Ku HC, Wu YL, et al
    Higher Risk of Depression After Total Mastectomy Versus Breast Reconstruction Among Adult Women With Breast Cancer: A Systematic Review and Metaregression.
    Clin Breast Cancer. 2021 Jan 7. pii: S1526-8209(21)00004.
    >> Share

  68. KIM HK, Lee HS, Heo MH, Kim JY, et al
    Ventriculoperitoneal Shunt for CNS Metastasis in Breast Cancer: Clinical Outcomes Based on Intrinsic Subtype.
    Clin Breast Cancer. 2021 Jan 6. pii: S1526-8209(21)00001.
    >> Share

  69. CHEN P, Chen R, Guo H, Cheng J, et al
    CASC15 Polymorphisms are Correlated With Breast Cancer Susceptibility in Chinese Han Women.
    Clin Breast Cancer. 2021 Jan 6. pii: S1526-8209(21)00006.
    >> Share

  70. VIDAL GA, Carter GC, Gilligan AM, Saverno K, et al
    Development of a Prognostic Factor Index Among Women With HR(+)/HER2(-) Metastatic Breast Cancer in a Community Oncology Setting.
    Clin Breast Cancer. 2021 Jan 1. pii: S1526-8209(20)30340.
    >> Share

    December 2020
  71. BRYCE Y, Bourguillon R, Vazquez JC, Ziv E, et al
    Prevalence, Outcome, and Management of Risk Factors in Patients With Breast Cancer With Peripheral Arterial Disease: A Tertiary Cancer Center's Experience.
    Clin Breast Cancer. 2020 Dec 30. pii: S1526-8209(20)30338.
    >> Share

  72. MAHTANI R, Kittaneh M, Kalinsky K, Mamounas E, et al
    Advances in Therapeutic Approaches for Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2020 Dec 29. pii: S1526-8209(20)30339.
    >> Share

  73. ZHAO RP, Li Z, Li C, Xu K, et al
    A Genetic Variant of the BTLA Gene is Related to Increased Risk and Clinical Manifestations of Breast Cancer in Chinese Women.
    Clin Breast Cancer. 2020 Dec 28. pii: S1526-8209(20)30337.
    >> Share

  74. XU N, Zhou J, He X, Ye S, et al
    Radiomics Model for Evaluating the Level of Tumor-Infiltrating Lymphocytes in Breast Cancer Based on Dynamic Contrast-Enhanced MRI.
    Clin Breast Cancer. 2020 Dec 28. pii: S1526-8209(20)30336.
    >> Share

  75. FERNANDES LE, Epstein CG, Bobe AM, Bell JSK, et al
    Real-world Evidence of Diagnostic Testing and Treatment Patterns in US Patients With Breast Cancer With Implications for Treatment Biomarkers From RNA Sequencing Data.
    Clin Breast Cancer. 2020 Dec 18. pii: S1526-8209(20)30296.
    >> Share

  76. SAGONA A, Gentile D, Anghelone CAP, Barbieri E, et al
    Ipsilateral Breast Cancer Recurrence: Characteristics, Treatment, and Long-Term Oncologic Results at a High-Volume Center.
    Clin Breast Cancer. 2020 Dec 17. pii: S1526-8209(20)30334.
    >> Share

  77. HUANG X, Mai J, Huang Y, He L, et al
    Radiomic Nomogram for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Therapy in Breast Cancer: Predictive Value of Staging Contrast-enhanced CT.
    Clin Breast Cancer. 2020 Dec 17. pii: S1526-8209(20)30332.
    >> Share

  78. BALASUBRAMANIAN I, Harding T, Boland MR, Ryan EJ, et al
    The Impact of Postoperative Wound Complications on Oncological Outcomes Following Immediate Breast Reconstruction for Breast Cancer: A Meta-analysis.
    Clin Breast Cancer. 2020 Dec 17. pii: S1526-8209(20)30333.
    >> Share

  79. CHEN X, Wang J, Fan Y, Luo Y, et al
    Primary Trastuzumab Resistance After (Neo)adjuvant Trastuzumab-containing Treatment for Patients With HER2-positive Breast Cancer in Real-world Practice.
    Clin Breast Cancer. 2020 Dec 16. pii: S1526-8209(20)30218.
    >> Share

  80. SATO J, Azuma K, Kinowaki K, Ikeda K, et al
    Combined Use of Immunoreactivities of RIG-I with Efp/TRIM25 for Predicting Prognosis of Patients With Estrogen Receptor-positive Breast Cancer.
    Clin Breast Cancer. 2020 Dec 9. pii: S1526-8209(20)30328.
    >> Share

  81. AL-SALEH K, Aldiab A, Salah T, Arafah M, et al
    Prognostic Significance of HER2 Expression Changes Following Neoadjuvant Chemotherapy in Saudi Patients With Locally Advanced Breast Cancer.
    Clin Breast Cancer. 2020 Dec 3. pii: S1526-8209(20)30324.
    >> Share

  82. CALI DAYLAN AE, Leone JP
    Targeted Therapies for Breast Cancer Brain Metastases.
    Clin Breast Cancer. 2020 Dec 1. pii: S1526-8209(20)30323.
    >> Share

  83. AMMAD UD DIN M, Jamshed S, Patel M
    Use of Immune Checkpoint Inhibitors in Early Triple-Negative Breast Cancer: Beyond the Early Conflicting Results.
    Clin Breast Cancer. 2020 Dec 1. pii: S1526-8209(20)30325.
    >> Share

    November 2020
  84. SHATNAWI A, Ayoub NM, Alkhalifa AE
    ING4 Expression Landscape and Association With Clinicopathologic Characteristics in Breast Cancer.
    Clin Breast Cancer. 2020 Nov 19. pii: S1526-8209(20)30295.
    >> Share

  85. SANNA G, Pestrin M, Moretti E, Biagioni C, et al
    A Dose-finding Study of Metronomic Oral Vinorelbine in Combination With Oral Cyclophosphamide and Bevacizumab in Patients With Advanced Breast Cancer.
    Clin Breast Cancer. 2020 Nov 19. pii: S1526-8209(20)30294.
    >> Share

  86. MANLEY H, Mutasa S, Chang P, Desperito E, et al
    Dynamic Changes of Convolutional Neural Network-based Mammographic Breast Cancer Risk Score Among Women Undergoing Chemoprevention Treatment.
    Clin Breast Cancer. 2020 Nov 17. pii: S1526-8209(20)30291.
    >> Share

  87. MURATA T, Watase C, Shiino S, Jimbo K, et al
    Development and Validation of a Preoperative Scoring System to Distinguish Between Nonadvanced and Advanced Axillary Lymph Node Metastasis in Patients With Early-stage Breast Cancer.
    Clin Breast Cancer. 2020 Nov 17. pii: S1526-8209(20)30292.
    >> Share

  88. GILBERT A, Williams C, Azuero A, Burkard ME, et al
    Utilizing Data Visualization to Identify Survival and Treatment Differences Between Women With De Novo and Recurrent Metastatic Breast Cancer.
    Clin Breast Cancer. 2020 Nov 17. pii: S1526-8209(20)30293.
    >> Share

  89. HAN Y, Wang J, Sun Y, Yu P, et al
    Prognostic Model and Nomogram for Estimating Survival of Small Breast Cancer: A SEER-based Analysis.
    Clin Breast Cancer. 2020 Nov 13. pii: S1526-8209(20)30290.
    >> Share

  90. FAHIM HH, Mohamed G, Safwat G, Abo-Bakr A, et al
    HSP70 as a Diagnostic and Prognostic Marker in Egyptian Women With Breast Cancer.
    Clin Breast Cancer. 2020 Nov 13. pii: S1526-8209(20)30289.
    >> Share

  91. KOZAR N, Kruusmaa K, Bitenc M, Argamasilla R, et al
    Identification of Novel Diagnostic Biomarkers in Breast Cancer Using Targeted Metabolomic Profiling.
    Clin Breast Cancer. 2020 Nov 11. pii: S1526-8209(20)30232.
    >> Share

  92. KOPETTI C, Schaffer C, Zaman K, Liapi A, et al
    Invasive Breast Cancer in a Trans Man After Bilateral Mastectomy: Case Report and Literature Review.
    Clin Breast Cancer. 2020 Nov 10. pii: S1526-8209(20)30264.
    >> Share

  93. LA VERDE N, Collova E, Blasi L, Pinotti G, et al
    Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study.
    Clin Breast Cancer. 2020 Nov 9. pii: S1526-8209(20)30272.
    >> Share

  94. FORTUNATO L, d'Amati G, Taffurelli M, Tinterri C, et al
    Severe Impact of Covid-19 Pandemic on Breast Cancer Care in Italy: A Senonetwork National Survey.
    Clin Breast Cancer. 2020 Nov 2. pii: S1526-8209(20)30271.
    >> Share

    October 2020
  95. KORUCU TS, Ucurum SG, Tastaban E, Ozgun H, et al
    Comparison of Shoulder-Arm Complex Pain, Function, and Scapular Dyskinesia in Women With and Without Unilateral Lymphedema After Breast Cancer Surgery.
    Clin Breast Cancer. 2020 Oct 29. pii: S1526-8209(20)30267.
    >> Share

  96. BRENES SANCHEZ JM, Picado AL, Olivares Crespo ME, Garcia Saenz JA, et al
    Breast Cancer Management During COVID-19 Pandemic in Madrid: Surgical Strategy.
    Clin Breast Cancer. 2020 Oct 24. pii: S1526-8209(20)30265.
    >> Share

  97. TAKALA L, Kuusinen TE, Skytta T, Kellokumpu-Lehtinen PL, et al
    Electronic Patient-reported Outcomes During Breast Cancer Adjuvant Radiotherapy.
    Clin Breast Cancer. 2020 Oct 20. pii: S1526-8209(20)30263.
    >> Share

  98. STRIGEL RM, Bravo E, Tevaarwerk AJ, Anderson BM, et al
    Development and Implementation of an Algorithm to Guide MRI Screening in Patients With a Personal History of Treated Breast Cancer.
    Clin Breast Cancer. 2020 Oct 17. pii: S1526-8209(20)30021.
    >> Share

  99. YANG W, He X, He C, Peng L, et al
    Impact of ESR1 Polymorphisms on Risk of Breast Cancer in the Chinese Han Population.
    Clin Breast Cancer. 2020 Oct 16. pii: S1526-8209(20)30262.
    >> Share

  100. BOSE S, Kalinsky K
    Durable Clinical Activity to the AKT Inhibitor Ipatasertib in a Heavily Pretreated Patient With an AKT1 E17K Mutant Metastatic Breast Cancer.
    Clin Breast Cancer. 2020 Oct 14. pii: S1526-8209(20)30261.
    >> Share

  101. CHAN A, Moy B, Mansi J, Ejlertsen B, et al
    Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.
    Clin Breast Cancer. 2020 Oct 6. pii: S1526-8209(20)30258.
    >> Share

  102. LOH ZJ, Wu TY, Cheng FT
    Evaluation of the Learning Curve in Robotic Nipple-sparing Mastectomy for Breast Cancer.
    Clin Breast Cancer. 2020 Oct 3. pii: S1526-8209(20)30257.
    >> Share

  103. SAMUEL EZIOKWU A, Varella L, Lynn Kruse M, Jia X, et al
    Real-world Outcomes of Cyclin-dependent Kinase Inhibitors Continued Beyond First Disease Progression in Hormone Receptor-positive Metastatic Breast Cancer.
    Clin Breast Cancer. 2020 Oct 2. pii: S1526-8209(20)30254.
    >> Share

    September 2020
  104. HAMILTON E, Cortes J, Ozyilkan O, Chen SC, et al
    nextMONARCH: Abemaciclib Monotherapy or Combined With Tamoxifen for Metastatic Breast Cancer.
    Clin Breast Cancer. 2020 Sep 30. pii: S1526-8209(20)30255.
    >> Share

  105. GOEL AK, Zamre V, Sharma G, Singh D, et al
    Immunohistochemical Markers as a Surrogate Method for Differentiation of Luminal Subtypes of Breast Cancer and Their Prognostic Significance.
    Clin Breast Cancer. 2020 Sep 28. pii: S1526-8209(20)30182.
    >> Share

  106. AGHAMOHAMMADI V, Salari-Moghaddam A, Benisi-Kohansal S, Taghavi M, et al
    Adherence to the MIND Diet and Risk of Breast Cancer: A Case-control Study.
    Clin Breast Cancer. 2020 Sep 24. pii: S1526-8209(20)30253.
    >> Share

  107. HAYASHI N, Yagata H, Tsugawa K, Kajiura Y, et al
    Response and Prognosis of Docetaxel and Cyclophosphamide as Neoadjuvant Chemotherapy in ER(+) HER2(-) Breast Cancer: A Prospective Phase II Study.
    Clin Breast Cancer. 2020 Sep 18. pii: S1526-8209(20)30233.
    >> Share

  108. DUAN X, Liu X, Cao Y, Li Y, et al
    Effect of MicroRNA-766 Promotes Proliferation, Chemoresistance, Migration, and Invasion of Breast Cancer Cells.
    Clin Breast Cancer. 2020 Sep 18. pii: S1526-8209(19)30720.
    >> Share

  109. MORANTE Z, Ruiz R, Araujo JM, Pinto JA, et al
    Impact of the Delayed Initiation of Adjuvant Chemotherapy in the Outcome of Triple Negative Breast Cancer.
    Clin Breast Cancer. 2020 Sep 18. pii: S1526-8209(20)30235.
    >> Share

  110. DE SANCTIS V, Alfo M, Vitiello C, Vullo G, et al
    Markers of Cardiotoxicity in Early Breast Cancer Patients Treated With a Hypofractionated Schedule: A Prospective Study.
    Clin Breast Cancer. 2020 Sep 10. pii: S1526-8209(20)30220.
    >> Share

  111. FRANCESCHINI D, Loi M, Chiola I, Arculeo S, et al
    Preliminary Results of a Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: Adjuvant Hypofractionated Whole Breast Irradiation Versus Accelerated Partial Breast Irradiation (HYPAB Trial).
    Clin Breast Cancer. 2020 Sep 9. pii: S1526-8209(20)30219.
    >> Share

  112. COCO S, Boccardo S, Mora M, Fontana V, et al
    Radiation-Related Deregulation of TUBB3 and BRCA1/2 and Risk of Secondary Lung Cancer in Women With Breast Cancer.
    Clin Breast Cancer. 2020 Sep 6. pii: S1526-8209(20)30216.
    >> Share

  113. CIURO J, Beyer A, Fritzler J, Jackson N, et al
    Health Care Disparities and Demand for Expanding Hereditary Breast Cancer Screening Guidelines in African Americans.
    Clin Breast Cancer. 2020 Sep 3. pii: S1526-8209(20)30215.
    >> Share

    August 2020
  114. SHAH OS, Soran A, Sahin M, Knapick BA, et al
    Identifying Genomic Alterations in Patients With Stage IV Breast Cancer Using MammaSeq: An International Collaborative Study.
    Clin Breast Cancer. 2020 Aug 20. pii: S1526-8209(20)30213.
    >> Share

  115. ANDRIKOPOULOU A, Zografos E, Liontos M, Koutsoukos K, et al
    Trastuzumab Deruxtecan (DS-8201a): The Latest Research and Advances in Breast Cancer.
    Clin Breast Cancer. 2020 Aug 18. pii: S1526-8209(20)30211.
    >> Share

  116. BILANI N, Elson L, Liang H, Elimimian EB, et al
    Effect of Surgery at Primary and Metastatic Sites in Patients with Stage IV Breast Cancer.
    Clin Breast Cancer. 2020 Aug 18. pii: S1526-8209(20)30214.
    >> Share

  117. COBB AN, Janjua HM, Kuo PC
    Big Data Solutions for Controversies in Breast Cancer Treatment.
    Clin Breast Cancer. 2020 Aug 12. pii: S1526-8209(20)30208.
    >> Share

  118. FILIPE MD, van Deukeren D, Kip M, Doeksen A, et al
    Effect of the COVID-19 Pandemic on Surgical Breast Cancer Care in the Netherlands: A Multicenter Retrospective Cohort Study.
    Clin Breast Cancer. 2020 Aug 7. pii: S1526-8209(20)30207.
    >> Share

  119. EARLY AP, Moon W
    Breast Cancer and Secondary Cancer Recurrences After Autologous Tissue Reconstruction.
    Clin Breast Cancer. 2020 Aug 3. pii: S1526-8209(20)30181.
    >> Share

    July 2020
  120. GADDAM S, Heller SL, Babb JS, Gao Y, et al
    Male Breast Cancer Risk Assessment and Screening Recommendations in High-Risk Men Who Undergo Genetic Counseling and Multigene Panel Testing.
    Clin Breast Cancer. 2020 Jul 25. pii: S1526-8209(20)30180.
    >> Share

  121. SAVVA C, Sadiq M, Sheikh O, Karim S, et al
    Werner Syndrome Protein Expression in Breast Cancer.
    Clin Breast Cancer. 2020 Jul 25. pii: S1526-8209(20)30179.
    >> Share

  122. RUIZ-CASADO A, Alvarez-Bustos A, de Pedro CG, Mendez-Otero M, et al
    Cancer-related Fatigue in Breast Cancer Survivors: A Review.
    Clin Breast Cancer. 2020 Jul 24. pii: S1526-8209(20)30177.
    >> Share

  123. MORIMOTO M, Toba H, Aoyama M, Nakagawa M, et al
    Phase 1 Dose-Escalation Study of Triweekly Nab-Paclitaxel Combined With S-1 for HER2-Negative Metastatic Breast Cancer.
    Clin Breast Cancer. 2020 Jul 24. pii: S1526-8209(20)30178.
    >> Share

  124. KIM DW, Kim JS, Kim K, Shin KH, et al
    Spontaneous Rib Fractures After Breast Cancer Treatment Based on Bone Scans: Comparison Of Conventional Versus Hypofractionated Radiotherapy.
    Clin Breast Cancer. 2020 Jul 23. pii: S1526-8209(20)30175.
    >> Share

  125. PARIS I, Di Giorgio D, Carbognin L, Corrado G, et al
    Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach.
    Clin Breast Cancer. 2020 Jul 20. pii: S1526-8209(20)30173.
    >> Share

  126. MCDONOUGH AL, Lei Y, Kwak AH, Haggett DE, et al
    Implementation of a Brief Screening Tool to Identify Needs of Breast Cancer Survivors.
    Clin Breast Cancer. 2020 Jul 15. pii: S1526-8209(20)30172.
    >> Share

  127. JOHN P, Osani MC, Kodali A, Buchsbaum R, et al
    Comparative Effectiveness of Adjuvant Chemotherapy in Early-Stage Breast Cancer: A Network Meta-analysis.
    Clin Breast Cancer. 2020 Jul 14. pii: S1526-8209(20)30171.
    >> Share

  128. HOU N, Xiao J, Wang Z, Wu Y, et al
    Development and Validation of a Nomogram for Individually Predicting Pathologic Complete Remission After Preoperative Chemotherapy in Chinese Breast Cancer: A Population-Based Study.
    Clin Breast Cancer. 2020 Jul 8. pii: S1526-8209(20)30154.
    >> Share

  129. JAMES J, Teo M, Ramachandran V, Law M, et al
    Looking for Metastasis in Early Breast Cancer: Does Bone Scan Help? A Retrospective Review.
    Clin Breast Cancer. 2020 Jul 8. pii: S1526-8209(20)30170.
    >> Share

  130. WANG S, Liu F, Ma H, Cui X, et al
    circCDYL Acts as a Tumor Suppressor in Triple Negative Breast Cancer by Sponging miR-190a-3p and Upregulating TP53INP1.
    Clin Breast Cancer. 2020 Jul 7. pii: S1526-8209(20)30084.
    >> Share

  131. WAN C, Williams CP, Nipp RD, Pisu M, et al
    Treatment Decision Making and Financial Toxicity in Women With Metastatic Breast Cancer.
    Clin Breast Cancer. 2020 Jul 6. pii: S1526-8209(20)30168.
    >> Share

  132. TUFANO AM, Teplinsky E, Landry CA
    Updates in Neoadjuvant Therapy for Triple Negative Breast Cancer.
    Clin Breast Cancer. 2020 Jul 3. pii: S1526-8209(20)30156.
    >> Share

  133. GOFF SL, Danforth DN
    The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer.
    Clin Breast Cancer. 2020 Jul 2. pii: S1526-8209(20)30155.
    >> Share

    June 2020
  134. MCCLELLAND S 3RD, Burney HN, Zellars RC, Ohri N, et al
    Predictors of Whole Breast Radiation Therapy Completion in Early Stage Breast Cancer Following Lumpectomy.
    Clin Breast Cancer. 2020 Jun 27. pii: S1526-8209(20)30150.
    >> Share

  135. QAZVINI MG, Salehi Z, Mashayekhi F, Saedi HS, et al
    A33512C and Intronic Poly(AT) Insertion/Deletion (PAT-/+) Polymorphisms of the XPC Gene and Their Association With the Risk of Breast Cancer.
    Clin Breast Cancer. 2020 Jun 19. pii: S1526-8209(20)30142.
    >> Share

  136. HWANG GS, Paranjpe R, Opsomer C, Lu K, et al
    Oral Endocrine Therapy Agent, Race/Ethnicity, and Time on Therapy Predict Adherence in Breast Cancer Patients in a Large Academic Institution.
    Clin Breast Cancer. 2020 Jun 13. pii: S1526-8209(20)30148.
    >> Share

  137. WANG J, Chen L, Nie Y, Wu W, et al
    Nomogram for Predicting the Overall Survival of Patients With Breast Cancer With Pathologic Nodal Status N3.
    Clin Breast Cancer. 2020 Jun 7. pii: S1526-8209(20)30146.
    >> Share

  138. JUANJUAN L, Santa-Maria CA, Hongfang F, Lingcheng W, et al
    Patient-reported Outcomes of Patients With Breast Cancer During the COVID-19 Outbreak in the Epicenter of China: A Cross-sectional Survey Study.
    Clin Breast Cancer. 2020 Jun 7. pii: S1526-8209(20)30147.
    >> Share

    May 2020
  139. LIN H, Zheng H, Ge C, Wang Q, et al
    The Effect of Adjuvant Treatment in Small Node-negative HER2-positive Breast Cancer: Which Subgroup Will Benefit?
    Clin Breast Cancer. 2020 May 27. pii: S1526-8209(20)30114.
    >> Share

  140. RATOSA I, Orazem M, Scoccimarro E, Steinacher M, et al
    Cyclin-Dependent Kinase 4/6 Inhibitors Combined With Radiotherapy for Patients With Metastatic Breast Cancer.
    Clin Breast Cancer. 2020 May 26. pii: S1526-8209(20)30115.
    >> Share

  141. COYNE K, Silverman P, Liu JH
    Oral GnRH Antagonist Ovarian Suppression After Escape From GnRH Agonist in Breast Cancer Patients.
    Clin Breast Cancer. 2020 May 26. pii: S1526-8209(20)30113.
    >> Share

  142. DINAN MA, Wilson LE, Reed SD, Griggs JJ, et al
    Association of 21-Gene Assay (OncotypeDX) Testing and Receipt of Chemotherapy in the Medicare Breast Cancer Patient Population Following Initial Adoption.
    Clin Breast Cancer. 2020 May 26. pii: S1526-8209(20)30112.
    >> Share

  143. CULLINANE C, Creavin B, O'Leary DP, O'Sullivan MJ, et al
    Can the Neutrophil to Lymphocyte Ratio Predict Complete Pathologic Response to Neoadjuvant Breast Cancer Treatment? A Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2020 May 16. pii: S1526-8209(20)30110.
    >> Share

  144. STASTNY I, Zubor P, Kajo K, Kubatka P, et al
    Aberrantly Methylated cfDNA in Body Fluids as a Promising Diagnostic Tool for Early Detection of Breast Cancer.
    Clin Breast Cancer. 2020 May 16. pii: S1526-8209(20)30111.
    >> Share

  145. FABI A, Mottolese M, Di Benedetto A, Sperati F, et al
    p53 and BLC2 Immunohistochemical Expression Across Molecular Subtypes in 1099 Early Breast Cancer Patients With Long-Term Follow-up: An Observational Study.
    Clin Breast Cancer. 2020 May 13. pii: S1526-8209(20)30107.
    >> Share

  146. FRANZESE C, Comito T, Vigano L, Pedicini V, et al
    Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer.
    Clin Breast Cancer. 2020 May 13. pii: S1526-8209(20)30108.
    >> Share

  147. ESCOTT CE, Zaenger D, Switchencko JM, Lin JY, et al
    The Influence of Histologic Grade on Outcomes of Elderly Women With Early Stage Breast Cancer Treated With Breast Conserving Surgery With or Without Radiotherapy.
    Clin Breast Cancer. 2020 May 13. pii: S1526-8209(20)30109.
    >> Share

  148. CO M, Kwong A
    Breast Cancer Rate and Mortality in Female Flight Attendants: A Systematic Review and Pooled Analysis.
    Clin Breast Cancer. 2020 May 12. pii: S1526-8209(20)30095.
    >> Share

  149. KONISHI T, Fujiogi M, Michihata N, Morita K, et al
    Impact of Body Mass Index on Outcomes After Breast Cancer Surgery: Nationwide Inpatient Database Study in Japan.
    Clin Breast Cancer. 2020 May 11. pii: S1526-8209(20)30094.
    >> Share

  150. ZHOU W, Chen X, Huang H, Liu S, et al
    Birth Weight and Incidence of Breast Cancer: Dose-Response Meta-analysis of Prospective Studies.
    Clin Breast Cancer. 2020 May 8. pii: S1526-8209(20)30089.
    >> Share

  151. KOZAK MM, Horst KC, Gutkin PM, Jacobson CE, et al
    Patterns of Failure in Women Who Have Residual Nodal Disease After Neoadjuvant Chemotherapy for Breast Cancer According to Extent of Lymph Node Surgery.
    Clin Breast Cancer. 2020 May 7. pii: S1526-8209(20)30086.
    >> Share

  152. DE SANTIS MC, La Rocca E, Vitullo A, Meattini I, et al
    Comment on "Combining Adjuvant Radiotherapy With Capecitabine in Chemotherapy-resistant Breast Cancer: Feasibility, Safety, and Toxicity".
    Clin Breast Cancer. 2020 May 6. pii: S1526-8209(20)30092.
    >> Share

  153. RITTER M, Paradiso V, Widmer P, Garofoli A, et al
    Identification of Somatic Mutations in Thirty-year-old Serum Cell-free DNA From Patients With Breast Cancer: A Feasibility Study.
    Clin Breast Cancer. 2020 May 6. pii: S1526-8209(20)30083.
    >> Share

  154. CIVIL YA, Duvivier KM, Perin P, Baan AH, et al
    Optimization of Wire-guided Technique With Bracketing Reduces Resection Volumes in Breast-conserving Surgery for Early Breast Cancer.
    Clin Breast Cancer. 2020 May 5. pii: S1526-8209(20)30091.
    >> Share

    April 2020
  155. ZHANG X, Yang H
    Research Progress on Long Non-coding RNAs and Drug Resistance of Breast Cancer.
    Clin Breast Cancer. 2020 Apr 30. pii: S1526-8209(19)30732.
    >> Share

  156. ZHANG X, Zhang Z, Cao M, Liu B, et al
    A Randomized Parallel Controlled Phase II Trial of Recombinant Human Endostatin Added to Neoadjuvant Chemotherapy for Stage III Breast Cancer.
    Clin Breast Cancer. 2020 Apr 28. pii: S1526-8209(20)30087.
    >> Share

  157. LV M, Mao Y, Song Y, Wang Y, et al
    Clinical Features and Survival of Single Hormone Receptor-Positive Breast Cancer: A Population-Based Study of 531,605 Patients.
    Clin Breast Cancer. 2020 Apr 24. pii: S1526-8209(20)30088.
    >> Share

  158. STATLER AB, Wei W, Gupta A, Blake CN, et al
    Elucidating Determinants of Survival Disparities Among a Real-world Cohort of Metastatic Breast Cancer Patients: A National Cancer Database Analysis.
    Clin Breast Cancer. 2020 Apr 18. pii: S1526-8209(20)30080.
    >> Share

  159. MUKHERJEE N, Panda CK
    Wnt/beta-Catenin Signaling Pathway as Chemotherapeutic Target in Breast Cancer: An Update on Pros and Cons.
    Clin Breast Cancer. 2020 Apr 18. pii: S1526-8209(20)30082.
    >> Share

  160. WANG K, Hackney JR, Siegal GP, Wei S, et al
    RANKLed by the Complexity of Signaling in Breast Cancer Metastasis to the Brain.
    Clin Breast Cancer. 2020 Apr 11. pii: S1526-8209(20)30071.
    >> Share

  161. CHANDARANA M, Tan YY, Kirby R, Jafferbhoy S, et al
    Patient-reported Upper Limb Function After Sentinel Lymph Node Biopsy for Breast Cancer: A Prospective Observational Study.
    Clin Breast Cancer. 2020 Apr 10. pii: S1526-8209(20)30070.
    >> Share

  162. SOMASHEKHAR SP, Kumar CR, Ashwin KR, Zaveri SS, et al
    Can Low-cost Indo Cyanine Green Florescence Technique for Sentinel Lymph Node Biopsy Replace Dual Dye (Radio-colloid and Blue Dye) Technique in Early Breast Cancer: A Prospective Two-arm Comparative Study.
    Clin Breast Cancer. 2020 Apr 6. pii: S1526-8209(20)30069.
    >> Share

  163. BEKES I, Eichler M, Singer S, Friedl TWP, et al
    Impact of Granulocyte Colony-Stimulating Factor (G-CSF) and Epoetin (EPO) on Hematologic Toxicities and Quality of Life in Patients During Adjuvant Chemotherapy in Early Breast Cancer: Results From the Multi-Center Randomized ADEBAR Trial.
    Clin Breast Cancer. 2020 Apr 6. pii: S1526-8209(20)30064.
    >> Share

  164. CASASANTA N, Amdur R, Kaltman R
    Response to Letter to the Editor: High Oncotype DX Recurrence Score, Hereditary Cancer Syndromes, and Referral for Germline Genetic Testing.
    Clin Breast Cancer. 2020;20:e198-e199.
    >> Share

  165. GOEL AK, Zamre V, Chaudhary P, Sharma G, et al
    High Oncotype Recurrence Score, Hereditary Cancer Syndromes, and Referral for Genetic Testing.
    Clin Breast Cancer. 2020;20:e196-e197.
    >> Share

  166. GUILLAUME Z, Medioni J, Lillo-Lelouet A, Marret G, et al
    Severe Cellular Immunodeficiency Triggered by the CDK4/6 Inhibitor Palbociclib.
    Clin Breast Cancer. 2020;20:e192-e195.
    >> Share

  167. FOUNTZILAS E, Konstantopoulou I, Vagena A, Apostolou P, et al
    Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections.
    Clin Breast Cancer. 2020;20:152-159.
    >> Share

  168. TU CW, Fang CL, Tsai CB, Hsu CH, et al
    Breast Reconstruction After Resection of Bilateral Giant Phyllodes Tumors: Two Separate Deep Inferior Epigastric Perforator Flaps From One Donor Site.
    Clin Breast Cancer. 2020;20:e188-e191.
    >> Share

  169. CUTULI B, Lemanski C, De Lafontan B, Chauvet MP, et al
    Ductal Carcinoma in Situ: A French National Survey. Analysis of 2125 Patients.
    Clin Breast Cancer. 2020;20:e164-e172.
    >> Share

  170. CASASANTA N, Kipnis ST, Linville L, Lipinski S, et al
    Relationship Between Hereditary Cancer Syndromes and Oncotype DX Recurrence Score.
    Clin Breast Cancer. 2020;20:125-130.
    >> Share

    March 2020
  171. HU J, Fung MW, Tsang JY, Poon IK, et al
    Improved Prognostication for the Updated AJCC Breast Cancer Pathological Prognostic Staging Varied in Higher-Stage Groups.
    Clin Breast Cancer. 2020 Mar 20. pii: S1526-8209(20)30027.
    >> Share

  172. LIAN J, Li K
    A Review of Breast Density Implications and Breast Cancer Screening.
    Clin Breast Cancer. 2020 Mar 20. pii: S1526-8209(20)30060.
    >> Share

  173. ABDEL-RAHMAN O
    Evaluating Family History Links between Breast Cancer and Prostate Cancer Among PLCO Trial Participants.
    Clin Breast Cancer. 2020 Mar 20. pii: S1526-8209(20)30061.
    >> Share

  174. ZHOU SC, Le J, Zhou J, Huang YX, et al
    The Role of Contrast-Enhanced Ultrasound in the Diagnosis and Pathologic Response Prediction in Breast Cancer: A Meta-analysis and Systematic Review.
    Clin Breast Cancer. 2020 Mar 20. pii: S1526-8209(20)30058.
    >> Share

  175. MALTONI R, Palleschi M, Altini M, Massa I, et al
    Are BMI and Negative Hormone Receptors Prognostic Factors in HER2(+) Early-stage Breast Cancer?
    Clin Breast Cancer. 2020 Mar 19. pii: S1526-8209(20)30026.
    >> Share

  176. EL ABBASS KA, Abdellateif MS, Gawish AM, Zekri AN, et al
    The Role of Breast Cancer Stem Cells and Some Related Molecular Biomarkers in Metastatic and Nonmetastatic Breast Cancer.
    Clin Breast Cancer. 2020 Mar 12. pii: S1526-8209(19)30756.
    >> Share

  177. POTTHOFF K, Stotzer O, Soling U, Hansen R, et al
    Effectiveness and Tolerability of Nab-paclitaxel in Younger versus Elderly Patients With Metastatic HR-positive/HER2-negative Breast Cancer: Results From the Noninterventional, Prospective Study NABUCCO.
    Clin Breast Cancer. 2020 Mar 10. pii: S1526-8209(19)30734.
    >> Share

  178. PARVEZ E, Martel K, Morency D, Dumitra S, et al
    Surgical and Oncologic Outcomes of Nipple-Sparing Mastectomy for a Cohort of Breast Cancer Patients, Including Cases with High-Risk Features.
    Clin Breast Cancer. 2020 Mar 8. pii: S1526-8209(20)30048.
    >> Share

  179. ZENG J, Gu Y, Fu H, Liu C, et al
    Association Between One-carbon Metabolism-related Vitamins and Risk of Breast Cancer: A Systematic Review and Meta-analysis of Prospective Studies.
    Clin Breast Cancer. 2020 Mar 6. pii: S1526-8209(20)30047.
    >> Share

  180. SHERRY AD, Mayer IA, Ayala-Peacock DN, Abramson VG, et al
    Combining Adjuvant Radiotherapy With Capecitabine in Chemotherapy-resistant Breast Cancer: Feasibility, Safety, and Toxicity.
    Clin Breast Cancer. 2020 Mar 6. pii: S1526-8209(20)30045.
    >> Share

  181. AGOSTINETTO E, Giordano L, Torrisi R, De Sanctis R, et al
    Biological Characteristics and Long-term Outcomes in Node-negative Breast Cancer.
    Clin Breast Cancer. 2020 Mar 6. pii: S1526-8209(20)30046.
    >> Share

  182. CAPARICA R, Richard F, Brandao M, Awada A, et al
    Prognostic and Predictive Impact of Beta-2 Adrenergic Receptor Expression in HER2-Positive Breast Cancer.
    Clin Breast Cancer. 2020 Mar 4. pii: S1526-8209(20)30023.
    >> Share

    February 2020
  183. SHI J, Shao X, Guo X, Fang W, et al
    Dietary Habits and Breast Cancer Risk: A Hospital-Based Case-Control Study in Chinese Women.
    Clin Breast Cancer. 2020 Feb 27. pii: S1526-8209(20)30042.
    >> Share

  184. HANDA S, Okuyama H, Yamamoto H, Nakamura S, et al
    Effectiveness of a Smartphone Application as a Support Tool for Patients Undergoing Breast Cancer Chemotherapy: A Randomized Controlled Trial.
    Clin Breast Cancer. 2020 Feb 26. pii: S1526-8209(20)30020.
    >> Share

  185. AKKIPRIK M, Koca S, Ugurlu MU, Ekren R, et al
    Response Assessment With Molecular Characterization of Circulating Tumor Cells and Plasma MicroRNA Profiling in Patients With Locally Advanced Breast Cancer During Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2020 Feb 26. pii: S1526-8209(20)30041.
    >> Share

  186. PARK JH, Choi IS, Han KD, Park H, et al
    Association Between Fatty Liver Index and Risk of Breast Cancer: A Nationwide Population-Based Study.
    Clin Breast Cancer. 2020 Feb 22. pii: S1526-8209(20)30039.
    >> Share

  187. SCHWARTZBERG LS, Vidal GA
    Targeting PIK3CA Alterations in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Advanced Breast Cancer: New Therapeutic Approaches and Practical Considerations.
    Clin Breast Cancer. 2020 Feb 20. pii: S1526-8209(20)30032.
    >> Share

  188. PARSONS BM, Meier DR, Richmond CS, Gurda GT, et al
    Acquisition of Cabozantinib-Sensitive MET D1228N Mutation During Progression on Crizotinib in MET-Amplified Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2020 Feb 19. pii: S1526-8209(20)30033.
    >> Share

  189. ALBESHAN SM, Hossain SZ, Mackey MG, Brennan PC, et al
    Can Breast Self-examination and Clinical Breast Examination Along With Increasing Breast Awareness Facilitate Earlier Detection of Breast Cancer in Populations With Advanced Stages at Diagnosis?
    Clin Breast Cancer. 2020 Feb 11. pii: S1526-8209(20)30031.
    >> Share

  190. THOMAS A, Rhoads A, Suhl J, Conway KM, et al
    Incidence and Survival by Human Epidermal Growth Factor Receptor 2 Status in Young Women With Stage I-III Breast Cancer: SEER, 2010-2016.
    Clin Breast Cancer. 2020 Feb 4. pii: S1526-8209(20)30030.
    >> Share

  191. LAENKHOLM AV, Jensen MB, Eriksen JO, Roslind A, et al
    Population-based Study of Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal Breast Cancer.
    Clin Breast Cancer. 2020 Feb 4. pii: S1526-8209(20)30029.
    >> Share

  192. BURKE EE, Laronga C, Sun W, DeBiase S, et al
    Implant-sparing Mastectomy: An Alternative for Women Undergoing Mastectomy With Retropectoral Implants.
    Clin Breast Cancer. 2020;20:e14-e19.
    >> Share

  193. AYDOGAN T, Sezgin E, Ilvan S, Yilmaz OC, et al
    Comparison of Radio-guided Occult Lesion Localization (ROLL) and Magnetic Occult Lesion Localization (MOLL) for Non-palpable Lesions: A Phantom Model Study.
    Clin Breast Cancer. 2020;20:e9-e13.
    >> Share

  194. SHUI R, Liang X, Li X, Liu Y, et al
    Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Detection in Invasive Breast Carcinoma: A Retrospective Study of 12,467 Patients From 19 Chinese Representative Clinical Centers.
    Clin Breast Cancer. 2020;20:e65-e74.
    >> Share

  195. ROBERTSON SJ, Pond GR, Hilton J, Petkiewicz SL, et al
    Selecting Patients for Oncotype DX Testing Using Standard Clinicopathologic Information.
    Clin Breast Cancer. 2020;20:61-67.
    >> Share

  196. FUSHIMI A, Kudo R, Takeyama H
    Do Decreased Breast Microcalcifications After Neoadjuvant Chemotherapy Predict Pathologic Complete Response?
    Clin Breast Cancer. 2020;20:e82-e88.
    >> Share

    January 2020
  197. BARROSO-SOUSA R, Krop IE, Trippa L, Tan-Wasielewski Z, et al
    A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer.
    Clin Breast Cancer. 2020 Jan 30. pii: S1526-8209(20)30028.
    >> Share

  198. HU Y, Wang S, Ding N, Li N, et al
    Platelet/Lymphocyte Ratio Is Superior to Neutrophil/Lymphocyte Ratio as a Predictor of Chemotherapy Response and Disease-free Survival in Luminal B-like (HER2(-)) Breast Cancer.
    Clin Breast Cancer. 2020 Jan 30. pii: S1526-8209(20)30024.
    >> Share

  199. KIM MK, Shin HC
    Risk Factors for Tamoxifen-Induced Ovarian Hyperstimulation in Breast Cancer Patients.
    Clin Breast Cancer. 2020 Jan 28. pii: S1526-8209(20)30019.
    >> Share

  200. MUNOZ-MONTANO W, Cabrera-Galeana P, Alvarado-Miranda A, Villarreal-Garza C, et al
    Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Different Phenotypes of Locally Advanced Breast Cancer During Neoadjuvant Systemic Treatment.
    Clin Breast Cancer. 2020 Jan 21. pii: S1526-8209(20)30001.
    >> Share

  201. XU M, Yuan Y, Yan P, Jiang J, et al
    Prognostic Significance of Androgen Receptor Expression in Triple Negative Breast Cancer: A Systematic Review and Meta-Analysis.
    Clin Breast Cancer. 2020 Jan 18. pii: S1526-8209(20)30018.
    >> Share

  202. KIM KN, Qureshi MM, Huang D, Ko NY, et al
    The Impact of Locoregional Treatment on Survival in Patients With Metastatic Breast Cancer: A National Cancer Database Analysis.
    Clin Breast Cancer. 2020 Jan 14. pii: S1526-8209(19)30769.
    >> Share

  203. KITTANEH M, Badve S, Caldera H, Coleman R, et al
    Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early-Stage Breast Cancer: Breast Cancer Therapy Expert Group (BCTEG).
    Clin Breast Cancer. 2020 Jan 8. pii: S1526-8209(20)30004.
    >> Share

  204. FARD ZT
    The Relationship Between eNOS Polymorphisms With Age, Smoking, Body Mass Index, and Clinicopathologic Parameters in Patients With Breast Cancer in Comparison With a Control Group.
    Clin Breast Cancer. 2020 Jan 7. pii: S1526-8209(20)30003.
    >> Share

  205. RASHAD N, Abdelhamid T, Shouman SA, Nassar H, et al
    Capecitabine-Based Chemoendocrine Combination as First-Line Treatment for Metastatic Hormone-Positive Metastatic Breast Cancer: Phase 2 Study.
    Clin Breast Cancer. 2020 Jan 7. pii: S1526-8209(20)30002.
    >> Share

    December 2019
  206. NACK E, Koffer PP, Blumberg CS, Leonard KL, et al
    New Cardiac Abnormalities After Radiotherapy in Breast Cancer Patients Treated With Trastuzumab.
    Clin Breast Cancer. 2019 Dec 19. pii: S1526-8209(19)30765.
    >> Share

  207. SAUDER CAM, Bateni SB, Davidson AJ, Nishijima DK, et al
    Breast Conserving Surgery Compared With Mastectomy in Male Breast Cancer: A Brief Systematic Review.
    Clin Breast Cancer. 2019 Dec 19. pii: S1526-8209(19)30763.
    >> Share

  208. MODI ND, Sorich MJ, Rowland A, McKinnon RA, et al
    Predicting Thrombocytopenia in Patients With Breast Cancer Treated With Ado-trastuzumab Emtansine.
    Clin Breast Cancer. 2019 Dec 7. pii: S1526-8209(19)30715.
    >> Share

  209. YOO TK, Kim SJ, Lee J, Lee SB, et al
    A N0 Predicting Model for Sentinel Lymph Node Biopsy Omission in Early Breast Cancer Upstaged From Ductal Carcinoma in Situ.
    Clin Breast Cancer. 2019 Dec 6. pii: S1526-8209(19)30760.
    >> Share

  210. TKACZUK KHR, Hawkins D, Yue B, Hicks D, et al
    Association of Serum Progranulin Levels With Disease Progression, Therapy Response and Survival in Patients With Metastatic Breast Cancer.
    Clin Breast Cancer. 2019 Dec 5. pii: S1526-8209(19)30758.
    >> Share

  211. HOPSON MB, Onishi M, Awad D, Buono D, et al
    Prospective Study Evaluating Changes in Bone Quality in Premenopausal Women With Breast Cancer Undergoing Adjuvant Chemotherapy.
    Clin Breast Cancer. 2019 Dec 5. pii: S1526-8209(19)30759.
    >> Share

    November 2019
  212. BROWN CL, McEvoy MP, Smith BL, Lanahan CR, et al
    Long-Term Outcomes of Multiple-Wire Localizations for More Extensive Breast Cancer: Multiple-Wire Excision Does Not Increase Recurrence, Unplanned Imaging, or Biopsies.
    Clin Breast Cancer. 2019 Nov 23. pii: S1526-8209(19)30737.
    >> Share

  213. ITANI N, Grogan N, Mott S, Phadke S, et al
    Metastatic Presentations of Previously Treated Early-Stage Breast Cancer Patients and Association With Survival.
    Clin Breast Cancer. 2019 Nov 21. pii: S1526-8209(19)30735.
    >> Share

    October 2019
  214. SABOUR S
    The Impact of Partial Weak Staining in Normal Breast Epithelium on the Reliability of Immunohistochemistry Results in HercepTest-positive Breast Cancer: Methodological Issues on Reliability and Correlation.
    Clin Breast Cancer. 2019 Oct 25. pii: S1526-8209(19)30716.
    >> Share

  215. PAULSSON AK, Fowble B, Lazar AA, Park C, et al
    Radiotherapy Utilization for Patients Over Age 60 With Early Stage Breast Cancer.
    Clin Breast Cancer. 2019 Oct 25. pii: S1526-8209(19)30719.
    >> Share

  216. CONTE B, Fabi A, Poggio F, Blondeaux E, et al
    T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational Study.
    Clin Breast Cancer. 2019 Oct 24. pii: S1526-8209(19)30671.
    >> Share

  217. SMITH J 2ND, Irwin A, Jensen L, Tedesco K, et al
    Phase II Study of Eribulin Mesylate Administered Biweekly in Patients With Human Epidermal Growth Factor Receptor-2-negative Metastatic Breast Cancer.
    Clin Breast Cancer. 2019 Oct 14. pii: S1526-8209(19)30714.
    >> Share

    September 2019
  218. HASKINS CB, Neuner JM, McDowell BD, Carnahan RM, et al
    Effects of Previous Medication Regimen Factors and Bipolar and Psychotic Disorders on Breast Cancer Endocrine Therapy Adherence.
    Clin Breast Cancer. 2019 Sep 30. pii: S1526-8209(19)30685.
    >> Share

  219. KIM K, Kim SS, Shin KH, Kim JH, et al
    Aggressive Surgical Excision of Supraclavicular Lymph Node Did Not Improve the Outcomes of Breast Cancer With Supraclavicular Lymph Node Involvement (KROG 16-14).
    Clin Breast Cancer. 2019 Sep 24. pii: S1526-8209(19)30684.
    >> Share

  220. MEISEL JL, Zhao J, Suo A, Zhang C, et al
    Clinicopathologic Factors Associated With Response to Neoadjuvant Anti-HER2-Directed Chemotherapy in HER2-Positive Breast Cancer.
    Clin Breast Cancer. 2019 Sep 18. pii: S1526-8209(19)30683.
    >> Share

  221. WANG D, Yang X, He J, Lin J, et al
    Impact of Regional Nodal Irradiation and Hypofractionated Whole-Breast Radiation on Long-Term Breast Retraction and Poor Cosmetic Outcome in Breast Cancer Survivors.
    Clin Breast Cancer. 2019 Sep 18. pii: S1526-8209(19)30665.
    >> Share

  222. LI Y, Wang YW, Chen X, Ma RR, et al
    MicroRNA-4472 Promotes Tumor Proliferation and Aggressiveness in Breast Cancer by Targeting RGMA and Inducing EMT.
    Clin Breast Cancer. 2019 Sep 11. pii: S1526-8209(19)30669.
    >> Share

  223. MOLLON LE, Anderson EJ, Dean JL, Warholak TL, et al
    A Systematic Literature Review of the Prognostic and Predictive Value of PIK3CA Mutations in HR(+)/HER2(-) Metastatic Breast Cancer.
    Clin Breast Cancer. 2019 Sep 10. pii: S1526-8209(19)30670.
    >> Share

  224. TAKAHASHI Y, Iwamoto T, Suzuki Y, Kajiwara Y, et al
    Evaluation of Therapeutic Target Gene Expression Based on Residual Cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.
    Clin Breast Cancer. 2019 Sep 9. pii: S1526-8209(19)30643.
    >> Share

  225. OZAKI A, Nomura S, Leppold C, Tsubokura M, et al
    Breast Cancer Provider Interval Length in Fukushima, Japan, After the 2011 Triple Disaster: A Long-Term Retrospective Study.
    Clin Breast Cancer. 2019 Sep 6. pii: S1526-8209(19)30652.
    >> Share

  226. RAZIS E, Kalogeras KT, Kotsantis I, Koliou GA, et al
    The Role of CXCL13 and CXCL9 in Early Breast Cancer.
    Clin Breast Cancer. 2019 Sep 5. pii: S1526-8209(19)30667.
    >> Share

  227. RUGO HS, Finn RS, Gelmon K, Joy AA, et al
    Progression-free Survival Outcome Is Independent of Objective Response in Patients With Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer Treated With Palbociclib Plus Letrozole Compared With Letrozol
    Clin Breast Cancer. 2019 Sep 5. pii: S1526-8209(19)30668.
    >> Share

  228. BINES J, Procter M, Restuccia E, Viale G, et al
    Incidence and Management of Diarrhea With Adjuvant Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
    Clin Breast Cancer. 2019 Sep 5. pii: S1526-8209(19)30656.
    >> Share

  229. KUO WL, Huang JJ, Huang YT, Chueh LF, et al
    Robot-assisted Mastectomy Followed by Immediate Autologous Microsurgical Free Flap Reconstruction: Techniques and Feasibility in Three Different Breast Cancer Surgical Scenarios.
    Clin Breast Cancer. 2019 Sep 4. pii: S1526-8209(19)30662.
    >> Share

  230. WU W, Zhong J, Chen J, Niu P, et al
    Prognostic and Therapeutic Significance of Adhesion-regulating Molecule 1 in Estrogen Receptor-positive Breast Cancer.
    Clin Breast Cancer. 2019 Sep 3. pii: S1526-8209(19)30654.
    >> Share

    August 2019
  231. LIU D, Zhou K
    BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction.
    Clin Breast Cancer. 2019 Aug 29. pii: S1526-8209(19)30664.
    >> Share

  232. FENN K, Maurer M, Lee SM, Crew KD, et al
    Phase 1 Study of Erlotinib and Metformin in Metastatic Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2019 Aug 29. pii: S1526-8209(19)30663.
    >> Share

  233. SAMMONS S, Shastry M, Dent S, Anders C, et al
    Practical Treatment Strategies and Future Directions After Progression While Receiving CDK4/6 Inhibition and Endocrine Therapy in Advanced HR(+)/HER2(-) Breast Cancer.
    Clin Breast Cancer. 2019 Aug 23. pii: S1526-8209(19)30659.
    >> Share

  234. LI Z, Tu Y, Wu Q, Wang Z, et al
    Clinical Characteristics and Outcomes of Single Versus Double Hormone Receptor-Positive Breast Cancer in 2 Large Databases.
    Clin Breast Cancer. 2019 Aug 22. pii: S1526-8209(19)30644.
    >> Share

  235. FREEDMAN RA, Gelman RS, Agar NYR, Santagata S, et al
    Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022.
    Clin Breast Cancer. 2019 Aug 22. pii: S1526-8209(19)30657.
    >> Share

  236. JIANG L, Li X, Kong X, Ma T, et al
    Galactogram Grading System for Identifying Breast Cancer With Nipple Discharge.
    Clin Breast Cancer. 2019 Aug 22. pii: S1526-8209(19)30658.
    >> Share

  237. LASHAM A, Fitzgerald SJ, Knowlton N, Robb T, et al
    A Predictor of Early Disease Recurrence in Patients With Breast Cancer Using a Cell-free RNA and Protein Liquid Biopsy.
    Clin Breast Cancer. 2019 Aug 22. pii: S1526-8209(19)30645.
    >> Share

  238. YOO SH, Kim TY, Kim M, Lee KH, et al
    Development of a Nomogram to Predict the Recurrence Score of 21-Gene Prediction Assay in Hormone Receptor-Positive Early Breast Cancer.
    Clin Breast Cancer. 2019 Aug 21. pii: S1526-8209(19)30655.
    >> Share

  239. PAVLOVIC R, Jankovic SM, Milovanovic JR, Stefanovic SM, et al
    The Safety of Local Hormonal Treatment for Vulvovaginal Atrophy in Women With Estrogen Receptor-positive Breast Cancer Who Are on Adjuvant Aromatase Inhibitor Therapy: Meta-analysis.
    Clin Breast Cancer. 2019 Aug 21. pii: S1526-8209(19)30651.
    >> Share

  240. DU Q, Che J, Jiang X, Li L, et al
    PD-L1 Acts as a Promising Immune Marker to Predict the Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.
    Clin Breast Cancer. 2019 Aug 21. pii: S1526-8209(19)30649.
    >> Share

  241. GUO JY, Wang MZ, Wang MS, Sun T, et al
    The Undervalued Effects of Polychlorinated Biphenyl Exposure on Breast Cancer.
    Clin Breast Cancer. 2019 Aug 21. pii: S1526-8209(19)30648.
    >> Share

  242. ABDEL-RAHMAN O
    Impact of NCI Socioeconomic Index on the Outcomes of Nonmetastatic Breast Cancer Patients: Analysis of SEER Census Tract-Level Socioeconomic Database.
    Clin Breast Cancer. 2019 Aug 21. pii: S1526-8209(19)30647.
    >> Share

  243. YOON GY, Chae EY, Cha JH, Shin HJ, et al
    Imaging and Clinicopathologic Features Associated With Pathologic Complete Response in HER2-positive Breast Cancer Receiving Neoadjuvant Chemotherapy With Dual HER2 Blockade.
    Clin Breast Cancer. 2019 Aug 21. pii: S1526-8209(19)30653.
    >> Share

  244. MAHTANI R, Holmes FA, Badve S, Caldera H, et al
    A Roundtable Discussion of the Breast Cancer Therapy Expert Group (BCTEG): Clinical Developments and Practice Guidance on Human Epidermal Growth Factor Receptor 2 (HER2)-positive Breast Cancer.
    Clin Breast Cancer. 2019 Aug 21. pii: S1526-8209(19)30640.
    >> Share

    July 2019
  245. SINGH J, Asad S, Zhang Y, Nock W, et al
    Aggressive Subsets of Metastatic Triple Negative Breast Cancer.
    Clin Breast Cancer. 2019 Jul 31. pii: S1526-8209(19)30160.
    >> Share

  246. TOSS A, Venturelli M, Sperduti I, Molinaro E, et al
    First-Line Treatment for Endocrine-Sensitive Bone-Only Metastatic Breast Cancer: Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2019 Jul 24. pii: S1526-8209(19)30418.
    >> Share

  247. WILKIE J, Schickli MA, Berger MJ, Lustberg M, et al
    Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast Cancer.
    Clin Breast Cancer. 2019 Jul 17. pii: S1526-8209(19)30112.
    >> Share

  248. CANTINI L, Pistelli M, Merloni F, Fontana A, et al
    Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients.
    Clin Breast Cancer. 2019 Jul 11. pii: S1526-8209(19)30081.
    >> Share

  249. DONG J, Esham KS, Boehm L, Karim SA, et al
    Timeliness of Treatment Initiation in Newly Diagnosed Patients With Breast Cancer.
    Clin Breast Cancer. 2019 Jul 11. pii: S1526-8209(18)30831.
    >> Share

  250. KOMOROWSKI AS, Warner E, MacKay HJ, Sahgal A, et al
    Incidence of Brain Metastases in Nonmetastatic and Metastatic Breast Cancer: Is There a Role for Screening?
    Clin Breast Cancer. 2019 Jul 11. pii: S1526-8209(18)30863.
    >> Share

    June 2019
  251. BLAND KA, Kirkham AA, Bovard J, Shenkier T, et al
    Effect of Exercise on Taxane Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer: A Randomized Controlled Trial.
    Clin Breast Cancer. 2019 Jun 27. pii: S1526-8209(19)30253.
    >> Share

  252. CATTELL RF, Kang JJ, Ren T, Huang PB, et al
    MRI Volume Changes of Axillary Lymph Nodes as Predictor of Pathologic Complete Responses to Neoadjuvant Chemotherapy in Breast Cancer.
    Clin Breast Cancer. 2019 Jun 26. pii: S1526-8209(19)30037.
    >> Share

  253. FERREIRA AR, Ribeiro J, Miranda A, Mayer A, et al
    Effectiveness of Adjuvant Ovarian Function Suppression in Premenopausal Women With Early Breast Cancer: A Multicenter Cohort Study.
    Clin Breast Cancer. 2019 Jun 26. pii: S1526-8209(19)30263.
    >> Share

  254. YARDLEY DA, Liggett W, Mainwaring M, Castrellon A, et al
    A Phase II Open Label Study of Everolimus in Combination With Endocrine Therapy in Resistant Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer.
    Clin Breast Cancer. 2019 Jun 26. pii: S1526-8209(19)30164.
    >> Share

  255. PATHAK M, Dwivedi SN, Deo SVS, Thakur B, et al
    Effectiveness of Added Targeted Therapies to Neoadjuvant Chemotherapy for Breast Cancer: A Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2019 Jun 20. pii: S1526-8209(19)30323.
    >> Share

  256. JIANG Y, Liu Y, Tan X, Yu S, et al
    TPX2 as a Novel Prognostic Indicator and Promising Therapeutic Target in Triple-negative Breast Cancer.
    Clin Breast Cancer. 2019 Jun 13. pii: S1526-8209(18)30866.
    >> Share

  257. LEVASSEUR N, Willemsma KA, Li H, Gondara L, et al
    Efficacy of Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in ER-positive Breast Cancer: Results From a Prospective Institutional Database.
    Clin Breast Cancer. 2019 Jun 11. pii: S1526-8209(19)30033.
    >> Share

  258. ROSSI L, McCartney A, Risi E, De Santo I, et al
    Cyclin-Dependent Kinase 4/6 Inhibitors in Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer.
    Clin Breast Cancer. 2019 Jun 11. pii: S1526-8209(19)30307.
    >> Share

  259. LIVINGSTON-ROSANOFF D, Schumacher J, Vande Walle K, Stankowski-Drengler T, et al
    Does Tumor Size Predict Response to Neoadjuvant Chemotherapy in the Modern Era of Biologically Driven Treatment? A Nationwide Study of US Breast Cancer Patients.
    Clin Breast Cancer. 2019 Jun 6. pii: S1526-8209(19)30303.
    >> Share

  260. FARES J, Kanojia D, Rashidi A, Ahmed AU, et al
    Diagnostic Clinical Trials in Breast Cancer Brain Metastases: Barriers and Innovations.
    Clin Breast Cancer. 2019 Jun 5. pii: S1526-8209(19)30262.
    >> Share

  261. BOEHM L, Weisberg T, Linendoll N, Damon AC, et al
    Development of Phase-Specific Breast Cancer Survivorship Care Plans.
    Clin Breast Cancer. 2019 Jun 5. pii: S1526-8209(19)30138.
    >> Share

    May 2019
  262. VAHEDNIA E, Shandiz FH, Bagherabad MB, Moezzi A, et al
    The Impact of CASP8 rs10931936 and rs1045485 Polymorphisms as well as the Haplotypes on Breast Cancer Risk: A Case-Control Study.
    Clin Breast Cancer. 2019 May 31. pii: S1526-8209(18)30646.
    >> Share

  263. GOEL S, Pernas S, Tan-Wasielewski Z, Barry WT, et al
    Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial.
    Clin Breast Cancer. 2019 May 30. pii: S1526-8209(19)30313.
    >> Share

  264. LI H, Chen Y, Wang X, Tang L, et al
    T1-2N0M0 Triple-Negative Breast Cancer Treated With Breast-Conserving Therapy Has Better Survival Compared to Mastectomy: A SEER Population-Based Retrospective Analysis.
    Clin Breast Cancer. 2019 May 30. pii: S1526-8209(19)30316.
    >> Share

  265. LAFRENIE RM, Speigl L, Buckner CA, Pawelec G, et al
    Frequency of Immune Cell Subtypes in Peripheral Blood Correlates With Outcome for Patients With Metastatic Breast Cancer Treated With High-Dose Chemotherapy.
    Clin Breast Cancer. 2019 May 27. pii: S1526-8209(19)30015.
    >> Share

  266. DREHER N, Hadeler EK, Hartman SJ, Wong EC, et al
    Fitbit Usage in Patients With Breast Cancer Undergoing Chemotherapy.
    Clin Breast Cancer. 2019 May 25. pii: S1526-8209(19)30229.
    >> Share

  267. HARPER NW, Hodges KB, Stewart RL, Wu J, et al
    Adjuvant Treatment of Triple-Negative Metaplastic Breast Cancer With Weekly Paclitaxel and Platinum Chemotherapy: Retrospective Case Review From a Single Institution.
    Clin Breast Cancer. 2019 May 24. pii: S1526-8209(19)30123.
    >> Share

  268. PARK G, Bae K, Hwang IY, Kim JS, et al
    Prediction of Residual Malignancy After Excisional Biopsy for Breast Cancer With Suspicious Microcalcifications: Comparison of Mammography and Magnetic Resonance Imaging.
    Clin Breast Cancer. 2019 May 18. pii: S1526-8209(19)30289.
    >> Share

  269. CHOW S, Wan BA, Pidduck W, Zhang L, et al
    Symptoms Predictive of Overall Quality of Life Using the Edmonton Symptom Assessment Scale in Breast Cancer Patients Receiving Radiotherapy.
    Clin Breast Cancer. 2019 May 18. pii: S1526-8209(19)30055.
    >> Share

  270. FARRA C, Fedda F, Tfayli A, Tawil A, et al
    The Impact of Partial Weak Staining in Normal Breast Epithelium on the Reliability of Immunohistochemistry Results in HercepTest-positive Breast Cancer.
    Clin Breast Cancer. 2019 May 18. pii: S1526-8209(18)30847.
    >> Share

  271. GORI S, Puglisi F, Moroso S, Fabi A, et al
    The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer.
    Clin Breast Cancer. 2019 May 18. pii: S1526-8209(19)30011.
    >> Share

  272. ZHOU Y, Simmons J, Jordan CD, Sonbol MB, et al
    Aspirin Treatment Effect and Association with PIK3CA Mutation in Breast Cancer: A Biomarker Analysis.
    Clin Breast Cancer. 2019 May 18. pii: S1526-8209(19)30066.
    >> Share

  273. GAO F, Ge R
    LOC643714 Polymorphisms Contribute to an Elevated Susceptibility to Breast Cancer: A Meta-analysis of 231,191 Subjects.
    Clin Breast Cancer. 2019 May 18. pii: S1526-8209(19)30241.
    >> Share

  274. STUEBER TN, Wischnewsky M, Leinert E, Diessner J, et al
    B(2) Prognostic Score: External Validation of a Clinical Decision-making Tool for Metastatic Breast Cancer.
    Clin Breast Cancer. 2019 May 3. pii: S1526-8209(18)30867.
    >> Share

  275. UPSHAW JN, Ruthazer R, Miller KD, Parsons SK, et al
    Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off.
    Clin Breast Cancer. 2019 May 2. pii: S1526-8209(18)30571.
    >> Share

    April 2019
  276. JHA S, Wyld L, Krishnaswamy PH
    The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2019 Apr 19. pii: S1526-8209(19)30078.
    >> Share

  277. XU L, Zhang Z, Xiang Q, Liu Q, et al
    Extended Adjuvant Therapy With Aromatase Inhibitors for Early Breast Cancer: A Meta-analysis of Randomized Controlled Trials.
    Clin Breast Cancer. 2019 Apr 19. pii: S1526-8209(18)30531.
    >> Share

  278. BRUFSKY A, Mitra D, Davis KL, Nagar SP, et al
    Treatment Patterns and Outcomes Associated With Palbociclib Plus Letrozole for Postmenopausal Women With HR(-)/HER2(-) Advanced Breast Cancer Enrolled in an Expanded Access Program.
    Clin Breast Cancer. 2019 Apr 18. pii: S1526-8209(18)30809.
    >> Share

  279. MRUGALA MM, Kim B, Sharma A, Johnson N, et al
    Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.
    Clin Breast Cancer. 2019 Apr 18. pii: S1526-8209(19)30099.
    >> Share

  280. GORNES H, Cabarrou B, Jouve E, Franchet C, et al
    Long-Term Follow-up of Immediate Latissimus Dorsi Flap Reconstruction After Neoadjuvant Chemotherapy and Radiotherapy for Invasive Breast Cancer.
    Clin Breast Cancer. 2019 Apr 17. pii: S1526-8209(19)30018.
    >> Share

  281. LI Y, Cui X, Yang YJ, Chen QQ, et al
    Serum sPD-1 and sPD-L1 as Biomarkers for Evaluating the Efficacy of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients.
    Clin Breast Cancer. 2019 Apr 11. pii: S1526-8209(18)30653.
    >> Share

  282. TIAINEN L, Hamalainen M, Luukkaala T, Tanner M, et al
    Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer.
    Clin Breast Cancer. 2019 Apr 4. pii: S1526-8209(18)30840.
    >> Share

    March 2019
  283. NAMURA M, Tsunoda H, Kobayashi D, Enokido K, et al
    The Loss of Lymph Node Metastases After Neoadjuvant Chemotherapy in Patients With Cytology-proven Axillary Node-positive Primary Breast Cancer.
    Clin Breast Cancer. 2019 Mar 11. pii: S1526-8209(18)30858.
    >> Share

  284. SILVER E, Wenger N, Xie Z, Elashoff D, et al
    Implementing a Population-Based Breast Cancer Risk Assessment Program.
    Clin Breast Cancer. 2019 Mar 11. pii: S1526-8209(18)30761.
    >> Share

  285. NUGENT BD, Ren D, Bender CM, Rosenzweig M, et al
    The Impact of Age and Adjuvant Chemotherapy Modifications on Survival Among Black Women With Breast Cancer.
    Clin Breast Cancer. 2019 Mar 7. pii: S1526-8209(18)30643.
    >> Share

  286. LARSEN V, Barlow WE, Yang JJ, Zhu Q, et al
    Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways Study.
    Clin Breast Cancer. 2019 Mar 6. pii: S1526-8209(18)30783.
    >> Share

  287. ALTUNDAG K
    Characteristics of Patients With Breast Cancer With Brain Metastases Who Live Longer Than 60 Months.
    Clin Breast Cancer. 2019 Mar 6. pii: S1526-8209(19)30105.
    >> Share

    February 2019
  288. WOODWARD N, De Boer RH, Redfern A, White M, et al
    Results From the First Multicenter, Open-label, Phase IIIb Study Investigating the Combination of Pertuzumab With Subcutaneous Trastuzumab and a Taxane in Patients With HER2-positive Metastatic Breast Cancer (SAPPHIRE).
    Clin Breast Cancer. 2019 Feb 27. pii: S1526-8209(18)30696.
    >> Share

  289. LANDERCASPER J, Ramirez LD, Borgert AJ, Ahmad HF, et al
    A Reappraisal of the Comparative Effectiveness of Lumpectomy Versus Mastectomy on Breast Cancer Survival: A Propensity Score-Matched Update From the National Cancer Data Base (NCDB).
    Clin Breast Cancer. 2019 Feb 21. pii: S1526-8209(18)30861.
    >> Share

  290. MATRAI Z, Ujhelyi M, Kovacs T, Kelemen P, et al
    Evaluation of a Retroglandular Oncoplastic Technique as a Standard Level I Oncoplastic Breast-Conserving Surgery: A Retrospective Clinicopathologic Study of 102 Patients With Breast Cancer.
    Clin Breast Cancer. 2019 Feb 20. pii: S1526-8209(18)30884.
    >> Share

  291. GIULIANI J, Bonetti A
    Palbociclib or Ribociclib in First-Line Treatment in Patients With Hormone Receptor-Positive/Human Epidermal Receptor 2-Negative Advanced or Metastatic Breast Cancer? A Perspective Based on Pharmacologic Costs.
    Clin Breast Cancer. 2019 Feb 16. pii: S1526-8209(18)30803.
    >> Share

  292. ARCIERO CA, Guo Y, Jiang R, Behera M, et al
    ER(+)/HER2(+) Breast Cancer Has Different Metastatic Patterns and Better Survival Than ER-/HER2(+) Breast Cancer.
    Clin Breast Cancer. 2019 Feb 14. pii: S1526-8209(18)30792.
    >> Share

  293. XIE Y, Li Y, Zhang Y, Zhang S, et al
    Fulvestrant 500 mg Versus Exemestane in Postmenopausal Women With Metastatic Breast Cancer Resistant to Adjuvant Nonsteroidal Aromatase Inhibitors in Clinical Practice: A Multicenter Retrospective Study.
    Clin Breast Cancer. 2019 Feb 7. pii: S1526-8209(18)30801.
    >> Share

  294. HENDERSON J, Adams P, Barber K
    Factors Determining Anthracycline Use in Hormone Receptor Positive, Early-Stage Breast Cancer.
    Clin Breast Cancer. 2019 Feb 7. pii: S1526-8209(18)30542.
    >> Share

  295. KLAR N, Rosenzweig M, Diergaarde B, Brufsky A, et al
    Features Associated With Long-Term Survival in Patients With Metastatic Breast Cancer.
    Clin Breast Cancer. 2019 Feb 6. pii: S1526-8209(18)30853.
    >> Share

  296. O'BRIEN GL, O'Mahony C, Cooke K, Kinneally A, et al
    Cost Minimization Analysis of Intravenous or Subcutaneous Trastuzumab Treatment in Patients With HER2-Positive Breast Cancer in Ireland.
    Clin Breast Cancer. 2019 Feb 6. pii: S1526-8209(18)30526.
    >> Share

  297. NATSIOPOULOS I, Intzes S, Liappis T, Zarampoukas K, et al
    Axillary Lymph Node Tattooing and Targeted Axillary Dissection in Breast Cancer Patients Who Presented as cN+ Before Neoadjuvant Chemotherapy and Became cN0 After Treatment.
    Clin Breast Cancer. 2019 Feb 6. pii: S1526-8209(18)30845.
    >> Share

    January 2019
  298. FERRIGNI E, Bergom C, Yin Z, Szabo A, et al
    Breast Cancer in Women Aged 80 Years or Older: An Analysis of Treatment Patterns and Disease Outcomes.
    Clin Breast Cancer. 2019 Jan 31. pii: S1526-8209(18)30705.
    >> Share

  299. HU J, Cuffolo G, Parulekar V, Chan V, et al
    The Results of Surveillance Imaging After Breast Conservation Surgery and Partial Breast Reconstruction With Chest Wall Perforator Flaps; A Qualitative Analysis Compared With Standard Breast-Conserving Surgery for Breast Cancer.
    Clin Breast Cancer. 2019 Jan 31. pii: S1526-8209(18)30842.
    >> Share

  300. OGIYA R, Sagara Y, Niikura N, Freedman RA, et al
    Impact of Subtype on Survival of Young Patients With Stage IV Breast Cancer.
    Clin Breast Cancer. 2019 Jan 29. pii: S1526-8209(18)30604.
    >> Share

  301. MAAJANI K, Jalali A, Alipour S, Khodadost M, et al
    The Global and Regional Survival Rate of Women With Breast Cancer: A Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2019 Jan 29. pii: S1526-8209(18)30780.
    >> Share

  302. ALTUNDAG DK
    Prognostic Significance of Obesity and Diabetes Mellitus in Women With Brain Metastases From Breast Cancer Should Be Revisited.
    Clin Breast Cancer. 2019 Jan 23. pii: S1526-8209(19)30021.
    >> Share

  303. MEYER C, Millan P, Gonzalez V, Spera G, et al
    Intensive Imaging Surveillance of Survivors of Breast Cancer May Increase Risk of Radiation-induced Malignancy.
    Clin Breast Cancer. 2019 Jan 23. pii: S1526-8209(18)30713.
    >> Share

  304. TANGALAKIS LL, Cortina CS, Son JD, Poirier J, et al
    Obesity Does Not Influence Management of Advanced Breast Cancer in the Elderly.
    Clin Breast Cancer. 2019 Jan 12. pii: S1526-8209(18)30520.
    >> Share

  305. CACHO-DIAZ B, Spinola-Marono H, Reynoso N, Gonzalez-Aguilar A, et al
    Role of Overweight, Obesity, and Comorbidities in the Prognosis of Patients With Breast Cancer With Brain Metastases.
    Clin Breast Cancer. 2019 Jan 7. pii: S1526-8209(18)30766.
    >> Share

  306. MOTAWI TMK, Zakhary NI, Darwish HA, Abdalla HM, et al
    Significance of Serum Survivin and -31G/C Gene Polymorphism in the Early Diagnosis of Breast Cancer in Egypt.
    Clin Breast Cancer. 2019 Jan 6. pii: S1526-8209(18)30704.
    >> Share

  307. HEMIDA MA, AbdElmoneim NA, Hewala TI, Rashad MM, et al
    Vitamin D Receptor in Breast Cancer Tissues and Its Relation to Estrogen Receptor Alpha (ER-alpha) Gene Expression and Serum 25-hydroxyvitamin D Levels in Egyptian Breast Cancer Patients: A Case-control Study.
    Clin Breast Cancer. 2019 Jan 6. pii: S1526-8209(18)30224.
    >> Share

  308. PAPLOMATA E, Zelnak A, Santa-Maria CA, Liu Y, et al
    Use of Everolimus and Trastuzumab in Addition to Endocrine Therapy in Hormone-Refractory Metastatic Breast Cancer.
    Clin Breast Cancer. 2019 Jan 3. pii: S1526-8209(18)30637.
    >> Share

    December 2018
  309. BLASCHKE SM, Gough KC, Chua BH, Francis PA, et al
    Implementation of a Multidisciplinary Model of Care for Women With Metastatic Breast Cancer: Challenges and Lessons Learned.
    Clin Breast Cancer. 2018 Dec 21. pii: S1526-8209(18)30567.
    >> Share

  310. NOUR ELDIN EEM, El-Readi MZ, Nour Eldein MM, Alfalki AA, et al
    8-Hydroxy-2'-deoxyguanosine as a Discriminatory Biomarker for Early Detection of Breast Cancer.
    Clin Breast Cancer. 2018 Dec 21. pii: S1526-8209(18)30631.
    >> Share

  311. BLACKWELL KL, Zaman K, Qin S, Tkaczuk KHR, et al
    Neratinib in Combination With Trastuzumab for the Treatment of Patients With Advanced HER2-positive Breast Cancer: A Phase I/II Study.
    Clin Breast Cancer. 2018 Dec 20. pii: S1526-8209(18)30576.
    >> Share

  312. TANINI S, Fisher AD, Meattini I, Bianchi S, et al
    Testosterone and Breast Cancer in Transmen: Case Reports, Review of the Literature, and Clinical Observation.
    Clin Breast Cancer. 2018 Dec 20. pii: S1526-8209(18)30518.
    >> Share

  313. ORTEGA V, Anton A, Garau I, Afonso N, et al
    Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study.
    Clin Breast Cancer. 2018 Dec 20. pii: S1526-8209(17)30144.
    >> Share

  314. LAN B, Ma F, Han M, Chen S, et al
    The Effect of Polymorphism in UGT1A4 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Patients With Breast Cancer in China.
    Clin Breast Cancer. 2018 Dec 19. pii: S1526-8209(18)30539.
    >> Share

  315. KAPILA AK, Herd A, Knife N, Chaplin P, et al
    A Prospective Cohort Study on the Impact of Reflexology in Patients With Breast Cancer Using the MYCaW Scale.
    Clin Breast Cancer. 2018 Dec 19. pii: S1526-8209(18)30423.
    >> Share

  316. SYMONDS L, Linden H, Gadi V, Korde L, et al
    Combined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer-A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib.
    Clin Breast Cancer. 2018 Dec 14. pii: S1526-8209(18)30655.
    >> Share

  317. ABDEL-RAHMAN O, Xu Y, Kong S, Dort J, et al
    Impact of Baseline Cardiovascular Comorbidity on Outcomes in Women With Breast Cancer: A Real-world, Population-based Study.
    Clin Breast Cancer. 2018 Dec 12. pii: S1526-8209(18)30506.
    >> Share

  318. VERNIERI C, Prisciandaro M, Milano M, Cona MS, et al
    Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles.
    Clin Breast Cancer. 2018 Dec 12. pii: S1526-8209(18)30638.
    >> Share

  319. DENG K, Mo S, Liu X, Chen J, et al
    Soy Foods Might Weaken the Sensitivity of Tamoxifen in Premenopausal Patients With Lumina A Subtype of Breast Cancer.
    Clin Breast Cancer. 2018 Dec 12. pii: S1526-8209(18)30645.
    >> Share

  320. BONNER SN, Clark C, Keating NL, Kouri EM, et al
    Examining Associations of Racial Residential Segregation With Patient Knowledge of Breast Cancer and Treatment Receipt.
    Clin Breast Cancer. 2018 Dec 8. pii: S1526-8209(18)30417.
    >> Share

    November 2018
  321. JACENE HA, Youn T, DiPiro PJ, Hu J, et al
    Metabolic Characterization of Inflammatory Breast Cancer With Baseline FDG-PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor Grade.
    Clin Breast Cancer. 2018 Nov 26. pii: S1526-8209(18)30508.
    >> Share

  322. GAGNO S, D'Andrea MR, Mansutti M, Zanusso C, et al
    A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study.
    Clin Breast Cancer. 2018 Nov 24. pii: S1526-8209(18)30679.
    >> Share

  323. THORNELOE RJ, Horne R, Side L, Wolf MS, et al
    Beliefs About Medication and Uptake of Preventive Therapy in Women at Increased Risk of Breast Cancer: Results From a Multicenter Prospective Study.
    Clin Breast Cancer. 2018 Nov 22. pii: S1526-8209(18)30533.
    >> Share

  324. EISMANN J, Heng YJ, Fleischmann-Rose K, Tobias AM, et al
    Interdisciplinary Management of Transgender Individuals at Risk for Breast Cancer: Case Reports and Review of the Literature.
    Clin Breast Cancer. 2018 Nov 14. pii: S1526-8209(18)30569.
    >> Share

  325. TANG Y, Wang Y, Wang X, Liu Y, et al
    A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast Cancer.
    Clin Breast Cancer. 2018 Nov 14. pii: S1526-8209(18)30454.
    >> Share

  326. MAINWARING W, Bowers J, Pham N, Pezzi T, et al
    Stereotactic Radiosurgery Versus Whole Brain Radiation Therapy: A Propensity Score Analysis and Predictors of Care for Patients With Brain Metastases From Breast Cancer.
    Clin Breast Cancer. 2018 Nov 12. pii: S1526-8209(18)30540.
    >> Share

  327. CHEN H, Zhang M, Wang M, Zhang P, et al
    Immediate Breast Reconstruction in De Novo Metastatic Breast Cancer: An Analysis of 563 Cases Based on the SEER Database.
    Clin Breast Cancer. 2018 Nov 5. pii: S1526-8209(18)30678.
    >> Share

  328. KOTOULA V, Tsakiri K, Koliou GA, Lazaridis G, et al
    Relapsed and De Novo Metastatic HER2-positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome.
    Clin Breast Cancer. 2018 Nov 5. pii: S1526-8209(18)30424.
    >> Share

  329. XIPING Z, Shuai Z, Feijiang Y, Bo C, et al
    Meta-analysis of the Correlation Between Schizophrenia and Breast Cancer.
    Clin Breast Cancer. 2018 Nov 3. pii: S1526-8209(18)30090.
    >> Share

  330. FARAROUEI M, Iqbal A, Rezaian S, Gheibi Z, et al
    Dietary Habits and Physical Activity are Associated With the Risk of Breast Cancer Among Young Iranian Women: A Case-control Study on 1010 Premenopausal Women.
    Clin Breast Cancer. 2018 Nov 2. pii: S1526-8209(18)30622.
    >> Share

  331. CHEN W, Zhang J, Huang L, Chen L, et al
    Detection of HER2-positive Circulating Tumor Cells Using the LiquidBiopsy System in Breast Cancer.
    Clin Breast Cancer. 2018 Nov 1. pii: S1526-8209(18)30500.
    >> Share

  332. WANG K, Zhu GQ, Shi Y, Li ZY, et al
    Long-Term Survival Differences Between T1-2 Invasive Lobular Breast Cancer and Corresponding Ductal Carcinoma After Breast-Conserving Surgery: A Propensity-Scored Matched Longitudinal Cohort Study.
    Clin Breast Cancer. 2018 Nov 1. pii: S1526-8209(18)30467.
    >> Share

    October 2018
  333. BREAUX A, Turner B, Wu X, Rai SN, et al
    Impact of 21-Gene Expression Assay on Staging Estrogen Receptor-Positive HER2-Negative Breast Cancer.
    Clin Breast Cancer. 2018 Oct 29. pii: S1526-8209(18)30561.
    >> Share

  334. BRANDINI DA SILVA FC, Jose da Silva J, Sarri AJ, Paiva CE, et al
    Comprehensive Validation Study of Quality-of-Life Questionnaire Using Objective Clinical Measures: Breast Cancer Treatment Outcome Scale (BCTOS), Brazilian Portuguese Version.
    Clin Breast Cancer. 2018 Oct 27. pii: S1526-8209(18)30512.
    >> Share

  335. PASSILDAS J, Collard O, Savoye AM, Dohou J, et al
    Impact of Chemotherapy-induced Menopause in Women of Childbearing Age With Non-metastatic Breast Cancer - Preliminary Results From the MENOCOR Study.
    Clin Breast Cancer. 2018 Oct 23. pii: S1526-8209(18)30373.
    >> Share

  336. HURRIA A, Soto-Perez-de-Celis E, Blanchard S, Burhenn P, et al
    A Phase II Trial of Older Adults With Metastatic Breast Cancer Receiving nab-Paclitaxel: Melding the Fields of Geriatrics and Oncology.
    Clin Breast Cancer. 2018 Oct 16. pii: S1526-8209(18)30328.
    >> Share

  337. DING S, Wu J, Lin C, Chen W, et al
    Predictors for Survival and Distribution of 21-Gene Recurrence Score in Patients With Pure Mucinous Breast Cancer: A SEER Population-Based Retrospective Analysis.
    Clin Breast Cancer. 2018 Oct 13. pii: S1526-8209(18)30393.
    >> Share

  338. KAUFMAN PA, Wildiers H, Freyer G, Kemeny M, et al
    Phase 1b Study of Trebananib Plus Paclitaxel and Trastuzumab in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer.
    Clin Breast Cancer. 2018 Oct 9. pii: S1526-8209(18)30451.
    >> Share

  339. PANDEY A, Brufsky AM
    Metastatic Breast Cancer Patient With Activating HER2 Exon 20 Insertion Mutation With Response to Poziotinib: Case Report of Compassionate Drug Use.
    Clin Breast Cancer. 2018 Oct 4. pii: S1526-8209(18)30317.
    >> Share

  340. XIAO YL, Wang K, Liu Q, Li J, et al
    Risk Reduction and Survival Benefit of Risk-Reducing Salpingo-oophorectomy in Hereditary Breast Cancer: Meta-analysis and Systematic Review.
    Clin Breast Cancer. 2018 Oct 4. pii: S1526-8209(18)30521.
    >> Share

  341. KAPILA AK, Hamdi M, Patel A
    Clinicians Should Actively Promote Exercise in Survivors of Breast Cancer.
    Clin Breast Cancer. 2018;18:e747-e749.
    >> Share

  342. GINZAC A, Thivat E, Mouret-Reynier MA, Dubray-Longeras P, et al
    Weight Evolution During Endocrine Therapy for Breast Cancer in Postmenopausal Patients: Effect of Initial Fat Mass Percentage and Previous Adjuvant Treatments.
    Clin Breast Cancer. 2018;18:e1093-e1102.
    >> Share

    September 2018
  343. PAN H, Zhang K, Wang M, Ling L, et al
    Palliative Local Surgery for Locally Advanced Breast Cancer Depending on Hormone Receptor Status in Elderly Patients.
    Clin Breast Cancer. 2018 Sep 27. pii: S1526-8209(18)30510.
    >> Share

  344. NAKAGAWA M, Ikeuchi M, Morimoto M, Takechi H, et al
    Phase II Study of S-1 Combined With Low-Dose Docetaxel as Neoadjuvant Chemotherapy for Operable Breast Cancer Patients (N-1 Study).
    Clin Breast Cancer. 2018 Sep 27. pii: S1526-8209(18)30262.
    >> Share

  345. KOWALCZYK R, Nowosielski K, Cedrych I, Krzystanek M, et al
    Factors Affecting Sexual Function and Body Image of Early-Stage Breast Cancer Survivors in Poland: A Short-Term Observation.
    Clin Breast Cancer. 2018 Sep 21. pii: S1526-8209(18)30474.
    >> Share

  346. BAWAZIR A, Bashateh N, Jradi H, Breik AB, et al
    Breast Cancer Screening Awareness and Practices Among Women Attending Primary Health Care Centers in the Ghail Bawazir District of Yemen.
    Clin Breast Cancer. 2018 Sep 20. pii: S1526-8209(18)30429.
    >> Share

  347. SHAKER OG, Senousy MA
    Association of SNP-SNP Interactions Between RANKL, OPG, CHI3L1, and VDR Genes With Breast Cancer Risk in Egyptian Women.
    Clin Breast Cancer. 2018 Sep 19. pii: S1526-8209(18)30444.
    >> Share

  348. WATSON GA, Deac O, Aslam R, O'Dwyer R, et al
    Real-World Experience of Palbociclib-Induced Adverse Events and Compliance With Complete Blood Count Monitoring in Women With Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer.
    Clin Breast Cancer. 2018 Sep 8. pii: S1526-8209(18)30507.
    >> Share

  349. HSU W, Zhou X, Petruse A, Chau N, et al
    Role of Clinical and Imaging Risk Factors in Predicting Breast Cancer Diagnosis Among BI-RADS 4 Cases.
    Clin Breast Cancer. 2018 Sep 5. pii: S1526-8209(18)30258.
    >> Share

  350. MCGEE SF, Vandermeer L, Mazzarello S, Sienkiewicz M, et al
    Physician Survey of Timing of Adjuvant Endocrine Therapy Relative to Radiotherapy in Early Stage Breast Cancer Patients.
    Clin Breast Cancer. 2018 Sep 4. pii: S1526-8209(18)30204.
    >> Share

    August 2018
  351. BERHILI S, Ouabdelmoumen A, Sbai A, Kebdani T, et al
    Radical Mastectomy Increases Psychological Distress in Young Breast Cancer Patients: Results of A Cross-sectional Study.
    Clin Breast Cancer. 2018 Aug 31. pii: S1526-8209(18)30522.
    >> Share

  352. XIE J, Yang Y, Sun J, Jiao Z, et al
    STEAP1 Inhibits Breast Cancer Metastasis and Is Associated With Epithelial-Mesenchymal Transition Procession.
    Clin Breast Cancer. 2018 Aug 30. pii: S1526-8209(18)30378.
    >> Share

  353. HAYASHI N, Tsunoda H, Namura M, Ochi T, et al
    Magnetic Resonance Imaging Combined With Second-look Ultrasonography in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Primary Breast Cancer Patients.
    Clin Breast Cancer. 2018 Aug 24. pii: S1526-8209(18)30234.
    >> Share

  354. YARDLEY DA, Shipley D, Zubkus J, Wright GL, et al
    A Randomized Phase II Study of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Operable HER2-negative Breast Cancer.
    Clin Breast Cancer. 2018 Aug 23. pii: S1526-8209(18)30132.
    >> Share

  355. PISTILLI B, Mazouni C, Zingarello A, Faron M, et al
    Individualized Prediction of Menses Recovery After Chemotherapy for Early-stage Breast Cancer: A Nomogram Developed From UNICANCER PACS04 and PACS05 Trials.
    Clin Breast Cancer. 2018 Aug 23. pii: S1526-8209(18)30264.
    >> Share

  356. HAMMER J, Geinitz H, Nieder C, Track C, et al
    Risk Factors for Local Relapse and Inferior Disease-free Survival After Breast-conserving Management of Breast Cancer: Recursive Partitioning Analysis of 2161 Patients.
    Clin Breast Cancer. 2018 Aug 22. pii: S1526-8209(18)30241.
    >> Share

  357. ALARCON ROJAS CA, Alvarez-Banuelos MT, Morales-Romero J, Suarez-Diaz H, et al
    Breast Cancer: Metastasis, Molecular Subtypes, and Overweight and Obesity in Veracruz, Mexico.
    Clin Breast Cancer. 2018 Aug 22. pii: S1526-8209(18)30366.
    >> Share

  358. THRIVENI K, Raju A, Kumar RV, Krishnamurthy S, et al
    Patterns of Relative Telomere Length is Associated With hTERT Gene Expression in the Tissue of Patients With Breast Cancer.
    Clin Breast Cancer. 2018 Aug 22. pii: S1526-8209(18)30372.
    >> Share

  359. YAN M, Abdi MA, Falkson C
    Axillary Management in Breast Cancer Patients: A Comprehensive Review of the Key Trials.
    Clin Breast Cancer. 2018 Aug 22. pii: S1526-8209(18)30448.
    >> Share

  360. GUILLEMOIS S, Patsouris A, Peyraga G, Chassain K, et al
    Cutaneous and Gastrointestinal Leukocytoclastic Vasculitis Induced by Palbociclib in a Metastatic Breast Cancer Patient: A Case Report.
    Clin Breast Cancer. 2018 Aug 14. pii: S1526-8209(18)30313.
    >> Share

  361. MARSCHNER N, Salat C, Soling U, Hansen R, et al
    Final Effectiveness and Safety Results of NABUCCO: Real-World Data From a Noninterventional, Prospective, Multicenter Study in 697 Patients With Metastatic Breast Cancer Treated With nab-Paclitaxel.
    Clin Breast Cancer. 2018 Aug 9. pii: S1526-8209(18)30064.
    >> Share

  362. RUGO HS, Roche H, Thomas E, Chung HC, et al
    Efficacy and Safety of Ixabepilone and Capecitabine in Patients With Advanced Triple-negative Breast Cancer: a Pooled Analysis From Two Large Phase III, Randomized Clinical Trials.
    Clin Breast Cancer. 2018 Aug 4. pii: S1526-8209(18)30266.
    >> Share

  363. SPORIKOVA Z, Koudelakova V, Trojanec R, Hajduch M, et al
    Genetic Markers in Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2018 Aug 4. pii: S1526-8209(18)30093.
    >> Share

  364. HE J, Gu Y, Zhang S
    Vitamin A and Breast Cancer Survival: A Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2018 Aug 4. pii: S1526-8209(18)30305.
    >> Share

  365. JI G, Zhang C, Guan S, Yao X, et al
    Erlotinib for Progressive Brain and Leptomeningeal Metastases From HER2-positive Breast Cancer After Treatment Failure With Trastuzumab and Lapatinib: Experience and Review of Literature.
    Clin Breast Cancer. 2018 Aug 4. pii: S1526-8209(18)30384.
    >> Share

    July 2018
  366. STEARNS V, Brufsky AM, Verma S, Cotter MJ, et al
    Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer.
    Clin Breast Cancer. 2018 Jul 30. pii: S1526-8209(18)30306.
    >> Share

  367. RAPHAEL J, Kiss A, Nofech-Mozes S, Trudeau M, et al
    Clinical Outcomes of Single Versus Double Hormone Receptor-Positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2018 Jul 29. pii: S1526-8209(18)30118.
    >> Share

  368. ALI OS, Shabayek MI, Seleem MM, Abdellateif HG, et al
    MicroRNAs 182 and 375 Sera Expression as Prognostic Biochemical Markers in Breast Cancer.
    Clin Breast Cancer. 2018 Jul 29. pii: S1526-8209(18)30232.
    >> Share

  369. ABDEL-RAHMAN O
    Impact of Regional Nodal Irradiation on the Outcomes of N1 Breast Cancer Patients Referred for Adjuvant Treatment: A Patient-Level Pooled Analysis of 2 Clinical Trials.
    Clin Breast Cancer. 2018 Jul 24. pii: S1526-8209(18)30085.
    >> Share

  370. CHEN X, Fan Y, Xu B
    Distinct Characteristics and Metastatic Behaviors of Late Recurrence in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2-negative Breast Cancer: A Single Institute Experience of More Than 10 Years.
    Clin Breast Cancer. 2018 Jul 24. pii: S1526-8209(18)30303.
    >> Share

  371. KURUNDKAR A, Gao X, Zhang K, Britt JP, et al
    Comparison of AJCC Anatomic and Clinical Prognostic Stage Groups in Breast Cancer: Analysis of 3322 Cases From a Single Institution.
    Clin Breast Cancer. 2018 Jul 17. pii: S1526-8209(18)30230.
    >> Share

  372. BUECHLER SA, Gokmen-Polar Y, Badve SS
    EarlyR: A Robust Gene Expression Signature for Predicting Outcomes of Estrogen Receptor-Positive Breast Cancer.
    Clin Breast Cancer. 2018 Jul 17. pii: S1526-8209(18)30012.
    >> Share

  373. MURTHY RK, Raghavendra AS, Hess KR, Fujii T, et al
    Neoadjuvant Pertuzumab-containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER-2/neu-positive Breast Cancer: A Retrospective, Single Institution Experience.
    Clin Breast Cancer. 2018 Jul 10. pii: S1526-8209(18)30009.
    >> Share

  374. LELIEVRE L, Clezardin P, Magaud L, Roche L, et al
    Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancer With Serum VEGF as Primary Endpoint: The NEOZOL Study.
    Clin Breast Cancer. 2018 Jul 10. pii: S1526-8209(18)30121.
    >> Share

  375. ABD-ELHAY FA, Elhusseiny KM, Kamel MG, Low SK, et al
    Negative Lymph Node Count and Lymph Node Ratio Are Associated With Survival in Male Breast Cancer.
    Clin Breast Cancer. 2018 Jul 7. pii: S1526-8209(18)30061.
    >> Share

  376. BAXTER DE, Kim B, Hanby AM, Verghese ET, et al
    Neoadjuvant Endocrine Therapy in Breast Cancer Upregulates the Cytotoxic Drug Pump ABCG2/BCRP, and May Lead to Resistance to Subsequent Chemotherapy.
    Clin Breast Cancer. 2018 Jul 6. pii: S1526-8209(18)30447.
    >> Share

  377. YEE C, Wang K, Asthana R, Drost L, et al
    Radiation-induced Skin Toxicity in Breast Cancer Patients: A Systematic Review of Randomized Trials.
    Clin Breast Cancer. 2018 Jul 4. pii: S1526-8209(18)30114.
    >> Share

    June 2018
  378. LIU N, Johnson KJ, Ma CX
    Male Breast Cancer: An Updated Surveillance, Epidemiology, and End Results Data Analysis.
    Clin Breast Cancer. 2018 Jun 27. pii: S1526-8209(18)30016.
    >> Share

  379. WANG J, Wang S, Tang Y, Jing H, et al
    Comparison of Treatment Outcomes With Breast-conserving Surgery Plus Radiotherapy Versus Mastectomy for Patients With Stage I Breast Cancer: A Propensity Score-matched Analysis.
    Clin Breast Cancer. 2018 Jun 27. pii: S1526-8209(18)30115.
    >> Share

  380. KUWAYAMA T, Nakamura S, Hayashi N, Takano T, et al
    Randomized Multicenter Phase II Trial of Neoadjuvant Therapy Comparing Weekly Nab-paclitaxel Followed by FEC With Docetaxel Followed by FEC in HER2(-) Early-stage Breast Cancer.
    Clin Breast Cancer. 2018 Jun 27. pii: S1526-8209(16)30572.
    >> Share

  381. NASEHI L, Sturgis CD, Sharma N, Turk P, et al
    Breast Cancer Risk Associated With Benign Intraductal Papillomas Initially Diagnosed on Core Needle Biopsy.
    Clin Breast Cancer. 2018 Jun 21. pii: S1526-8209(18)30228.
    >> Share

  382. SHEEHY EM, Lehane E, Quinn E, Livingstone V, et al
    Information Needs of Patients With Breast Cancer at Years One, Three, and Five After Diagnosis.
    Clin Breast Cancer. 2018 Jun 18. pii: S1526-8209(18)30130.
    >> Share

  383. CHEN J, Wu X, Christos P, Yan W, et al
    Adjuvant Radiation Therapy for T3N0 Breast Cancer Patients Older Than 75 Years After Mastectomy: A SEER Analysis.
    Clin Breast Cancer. 2018 Jun 15. pii: S1526-8209(17)30641.
    >> Share

  384. ZHU X, Huang JM, Zhang K, Xia LJ, et al
    Diagnostic Value of Contrast-Enhanced Spectral Mammography for Screening Breast Cancer: Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2018 Jun 15. pii: S1526-8209(18)30008.
    >> Share

  385. KIM Y, Sim SH, Park B, Lee KS, et al
    Magnetic Resonance Imaging (MRI) Assessment of Residual Breast Cancer After Neoadjuvant Chemotherapy: Relevance to Tumor Subtypes and MRI Interpretation Threshold.
    Clin Breast Cancer. 2018 Jun 7. pii: S1526-8209(18)30300.
    >> Share

  386. MORI H, Kubo M, Kai M, Velasquez VV, et al
    BRCAness Combined With a Family History of Cancer Is Associated With a Poor Prognosis for Breast Cancer Patients With a High Risk of BRCA Mutations.
    Clin Breast Cancer. 2018 Jun 2. pii: S1526-8209(18)30022.
    >> Share

    May 2018
  387. SIOTOS C, McColl M, Psoter K, Gilmore RC, et al
    Tumor Site and Breast Cancer Prognosis.
    Clin Breast Cancer. 2018 May 29. pii: S1526-8209(18)30299.
    >> Share

  388. KIM HJ, Kang E, Kim JH, Kim SH, et al
    Survival Benefit of Surgical Removal of Primary Tumor in Patients With Stage IV Breast Cancer.
    Clin Breast Cancer. 2018 May 28. pii: S1526-8209(18)30104.
    >> Share

  389. CHEN M, Pockaj B, Andreozzi M, Barrett MT, et al
    JAK2 and PD-L1 Amplification Enhance the Dynamic Expression of PD-L1 in Triple-negative Breast Cancer.
    Clin Breast Cancer. 2018 May 26. pii: S1526-8209(17)30780.
    >> Share

  390. LECLERC AF, Slomian J, Jerusalem G, Coucke P, et al
    Exercise and Education Program After Breast Cancer: Benefits on Quality of Life and Symptoms at 3, 6, 12, and 24 Months' Follow-up.
    Clin Breast Cancer. 2018 May 19. pii: S1526-8209(17)30809.
    >> Share

  391. CO M, Ng J, Kwong A
    Air Travel Safety in Postoperative Breast Cancer Patients: A Systematic Review.
    Clin Breast Cancer. 2018 May 17. pii: S1526-8209(18)30236.
    >> Share

  392. KOZAK MM, Jacobson CE, von Eyben R, Walck E, et al
    Patterns of Distant Failure by Intrinsic Breast Cancer Subtype in Premenopausal Women Treated With Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2018 May 7. pii: S1526-8209(17)30796.
    >> Share

  393. MCINTIRE PJ, Irshaid L, Liu Y, Chen Z, et al
    Hot Spot and Whole-Tumor Enumeration of CD8(+) Tumor-Infiltrating Lymphocytes Utilizing Digital Image Analysis Is Prognostic in Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2018 May 7. pii: S1526-8209(17)30839.
    >> Share

  394. DENG Y, Ma G, Li W, Wang T, et al
    CDK4/6 Inhibitors in Combination With Hormone Therapy for HR(+)/HER2(-) Advanced Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Clin Breast Cancer. 2018 May 4. pii: S1526-8209(17)30798.
    >> Share

  395. JABIR RS, Ho GF, Annuar MABA, Stanslas J, et al
    Association of Allelic Interaction of Single Nucleotide Polymorphisms of Influx and Efflux Transporters Genes With Nonhematologic Adverse Events of Docetaxel in Breast Cancer Patients.
    Clin Breast Cancer. 2018 May 4. pii: S1526-8209(17)30628.
    >> Share

    April 2018
  396. LADWA R, Kalas T, Pathmanathan S, Woodward N, et al
    Maintaining Dose Intensity of Adjuvant Chemotherapy in Older Patients With Breast Cancer.
    Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(18)30105.
    >> Share

  397. DHAKAL A, Matthews CM, Levine EG, Salerno KE, et al
    Efficacy of Palbociclib Combinations in Hormone Receptor-Positive Metastatic Breast Cancer Patients After Prior Everolimus Treatment.
    Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(17)30805.
    >> Share

  398. KOPS NL, Bessel M, Caleffi M, Ribeiro RA, et al
    Body Weight and Breast Cancer: Nested Case-Control Study in Southern Brazil.
    Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(18)30073.
    >> Share

  399. RAYSON D, Payne JI, Michael JCR, Tsuruda KM, et al
    Impact of Detection Method and Age on Survival Outcomes in Triple-Negative Breast Cancer: A Population-Based Cohort Analysis.
    Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(17)30829.
    >> Share

  400. CHO WK, Choi DH, Park W, Cha H, et al
    Effect of Body Mass Index on Survival in Breast Cancer Patients According to Subtype, Metabolic Syndrome, and Treatment.
    Clin Breast Cancer. 2018 Apr 19. pii: S1526-8209(17)30765.
    >> Share

  401. QINGQING H, Jian Z, Dayong Z, Ziyi F, et al
    Robot-Assisted Internal Mammary Lymph Node Chain Dissection for Breast Cancer.
    Clin Breast Cancer. 2018 Apr 19. pii: S1526-8209(18)30134.
    >> Share

  402. KIM HJ, Lee MH, Lee JE, Park S, et al
    Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy.
    Clin Breast Cancer. 2018 Apr 19. pii: S1526-8209(18)30019.
    >> Share

  403. HU ZY, Xiao H, Xiao M, Tang Y, et al
    Inducing or Preventing Subsequent Malignancies for Breast Cancer Survivors? Double-edged Sword of Estrogen Receptor and Progesterone Receptor.
    Clin Breast Cancer. 2018 Apr 19. pii: S1526-8209(18)30048.
    >> Share

  404. KENDZIERSKI DC, Schneider BP, Kiel PJ
    Efficacy of Different Leuprolide Administration Schedules in Premenopausal Breast Cancer: A Retrospective Review.
    Clin Breast Cancer. 2018 Apr 18. pii: S1526-8209(17)30722.
    >> Share

  405. CADOO KA, Kaufman PA, Seidman AD, Chang C, et al
    Phase 2 Study of Dose-Dense Doxorubicin and Cyclophosphamide Followed by Eribulin Mesylate With or Without Prophylactic Growth Factor for Adjuvant Treatment of Early-Stage Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
    Clin Breast Cancer. 2018 Apr 7. pii: S1526-8209(17)30768.
    >> Share

  406. NG T, Phey XY, Yeo HL, Shwe M, et al
    Impact of Adjuvant Anthracycline-Based and Taxane-Based Chemotherapy on Plasma VEGF Levels and Cognitive Function in Breast Cancer Patients: A Longitudinal Study.
    Clin Breast Cancer. 2018 Apr 6. pii: S1526-8209(17)30767.
    >> Share

  407. MUTSCHLER NS, Scholz C, Friedl TWP, Zwingers T, et al
    Prognostic Impact of Weight Change During Adjuvant Chemotherapy in Patients With High-Risk Early Breast Cancer: Results From the ADEBAR Study.
    Clin Breast Cancer. 2018;18:175-183.
    >> Share

    March 2018
  408. CORTES J, Perez-Garcia J, Whiting S, Wan Y, et al
    Quality-Adjusted Survival With nab-Paclitaxel Versus Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis.
    Clin Breast Cancer. 2018 Mar 30. pii: S1526-8209(17)30778.
    >> Share

  409. KIM S, Moon BI, Lim W, Park S, et al
    Feasibility of Classification of Triple Negative Breast Cancer by Immunohistochemical Surrogate Markers.
    Clin Breast Cancer. 2018 Mar 23. pii: S1526-8209(17)30736.
    >> Share

  410. TAHERIPANAH R, Balash F, Anbiaee R, Mahmoodi M, et al
    Breast Cancer and Ovulation Induction Treatments.
    Clin Breast Cancer. 2018 Mar 15. pii: S1526-8209(17)30455.
    >> Share

  411. MORRIS PG, Rota S, Cadoo K, Zamora S, et al
    Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer.
    Clin Breast Cancer. 2018 Mar 15. pii: S1526-8209(17)30810.
    >> Share

  412. UM E, Kang JW, Lee S, Kim HJ, et al
    Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
    Clin Breast Cancer. 2018 Mar 15. pii: S1526-8209(17)30614.
    >> Share

  413. MATTHIESSEN LW, Keshtgar M, Curatolo P, Kunte C, et al
    Electrochemotherapy for Breast Cancer-Results From the INSPECT Database.
    Clin Breast Cancer. 2018 Mar 14. pii: S1526-8209(17)30397.
    >> Share

  414. REINERT T, Nogueira-Rodrigues A, Kestelman FP, Ashton-Prolla P, et al
    The Challenge of Evaluating Adnexal Masses in Patients With Breast Cancer.
    Clin Breast Cancer. 2018 Mar 12. pii: S1526-8209(18)30026.
    >> Share

  415. MIYAGAWA Y, Araki K, Bun A, Ozawa H, et al
    Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-Paclitaxel.
    Clin Breast Cancer. 2018 Mar 8. pii: S1526-8209(17)30724.
    >> Share

  416. COSPHIADI I, Atmakusumah TD, Siregar NC, Muthalib A, et al
    Bone Metastasis in Advanced Breast Cancer: Analysis of Gene Expression Microarray.
    Clin Breast Cancer. 2018 Mar 8. pii: S1526-8209(17)30777.
    >> Share

  417. YARDLEY DA, Hart LL, Ward PJ, Wright GL, et al
    Cabazitaxel Plus Lapatinib as Therapy for HER2(+) Metastatic Breast Cancer With Intracranial Metastases: Results of a Dose-finding Study.
    Clin Breast Cancer. 2018 Mar 8. pii: S1526-8209(17)30668.
    >> Share

  418. MEATTINI I, Pezzulla D, Saieva C, Bernini M, et al
    Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study.
    Clin Breast Cancer. 2018 Mar 2. pii: S1526-8209(18)30015.
    >> Share

    February 2018
  419. BINKLEY JM, Stratford P, Kirkpatrick S, Farley CR, et al
    Estimating the Reliability and Validity of the Upper Extremity Functional Index in Women After Breast Cancer Surgery.
    Clin Breast Cancer. 2018 Feb 21. pii: S1526-8209(18)30054.
    >> Share

  420. DEFAZIO MV, Dervishaj OA, Bozzuto LM, Pittman TA, et al
    Delayed Recurrent and Bilateral Breast Cancer in Patients With Partial Poland's Anomaly: Report of 2 Rare Cases and Review of the Literature.
    Clin Breast Cancer. 2018 Feb 20. pii: S1526-8209(17)30842.
    >> Share

  421. HERSKOVIC AC, Wu X, Christos PJ, Nagar H, et al
    Omission of Adjuvant Radiotherapy in the Elderly Breast Cancer Patient: Missed Opportunity?
    Clin Breast Cancer. 2018 Feb 20. pii: S1526-8209(17)30782.
    >> Share

  422. RAO N, Chen K, Yang Q, Niu J, et al
    Proof-of-Concept Study of 3-D-Printed Mold-Guided Breast-Conserving Surgery in Breast Cancer Patients.
    Clin Breast Cancer. 2018 Feb 20. pii: S1526-8209(18)30039.
    >> Share

  423. YAMASHITA N, Tokunaga E, Iimori M, Inoue Y, et al
    Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer.
    Clin Breast Cancer. 2018 Feb 16. pii: S1526-8209(17)30629.
    >> Share

  424. ZAHEDI H, Djalalinia S, Sadeghi O, Asayesh H, et al
    Dietary Inflammatory Potential Score and Risk of Breast Cancer: Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2018 Feb 7. pii: S1526-8209(17)30725.
    >> Share

  425. PALAZZO A, Dellapasqua S, Munzone E, Bagnardi V, et al
    Phase II Trial of Bevacizumab Plus Weekly Paclitaxel, Carboplatin, and Metronomic Cyclophosphamide With or Without Trastuzumab and Endocrine Therapy as Preoperative Treatment of Inflammatory Breast Cancer.
    Clin Breast Cancer. 2018 Feb 2. pii: S1526-8209(17)30737.
    >> Share

  426. CUI Q, Kong D, Li Z, Ahiable P, et al
    Dachshund 1 is Differentially Expressed Between Male and Female Breast Cancer: A Matched Case-Control Study of Clinical Characteristics and Prognosis.
    Clin Breast Cancer. 2018 Feb 2. pii: S1526-8209(17)30662.
    >> Share

  427. BLACKWELL K, Gligorov J, Jacobs I, Twelves C, et al
    The Global Need for a Trastuzumab Biosimilar for Patients With HER2-Positive Breast Cancer.
    Clin Breast Cancer. 2018 Feb 2. pii: S1526-8209(17)30406.
    >> Share

    January 2018
  428. HASHEMI M, Sanaei S, Hashemi SM, Eskandari E, et al
    Association of Single Nucleotide Polymorphisms of the MDM4 Gene With the Susceptibility to Breast Cancer in a Southeast Iranian Population Sample.
    Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(17)30804.
    >> Share

  429. ERSOY YE, Kadioglu H
    Review of Novel Sentinel Lymph Node Biopsy Techniques in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(17)30830.
    >> Share

  430. JABIR FA, Hoidy WH
    Pharmacogenetics as Personalized Medicine: Association Investigation of SOD2 rs4880, CYP2C19 rs4244285, and FCGR2A rs1801274 Polymorphisms in a Breast Cancer Population in Iraqi Women.
    Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(17)30534.
    >> Share

  431. FARD ZT, Nafisi N
    The Relationship Between 6 Polymorphisms of Caveolin-1 Gene and the Risk of Breast Cancer.
    Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(16)30439.
    >> Share

  432. KOJIMA Y, Kawamoto H, Nishikawa T, Hayami R, et al
    Feasibility Study of Weekly Nanoparticle Albumin-Bound Paclitaxel (150 mg/m(2)) Followed by Fluorouracil, Epirubicin, and Cyclophosphamide Therapy as Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.
    Clin Breast Cancer. 2018 Jan 11. pii: S1526-8209(17)30615.
    >> Share

  433. GU J, Groot G, Boden C, Busch A, et al
    Review of Factors Influencing Women's Choice of Mastectomy Versus Breast Conserving Therapy in Early Stage Breast Cancer: A Systematic Review.
    Clin Breast Cancer. 2018 Jan 3. pii: S1526-8209(17)30691.
    >> Share

    December 2017
  434. YADAV S, Ladkany R, Yadav D, Alhalabi O, et al
    Impact of BRCA Mutation Status on Survival of Women With Triple-negative Breast Cancer.
    Clin Breast Cancer. 2017 Dec 30. pii: S1526-8209(17)30334.
    >> Share

  435. WU JD, Hong CQ, Huang WH, Wei XL, et al
    L1 Cell Adhesion Molecule and Its Soluble Form sL1 Exhibit Poor Prognosis in Primary Breast Cancer Patients.
    Clin Breast Cancer. 2017 Dec 28. pii: S1526-8209(17)30523.
    >> Share

  436. BHAVE MA, Speth KA, Kidwell KM, Lyden A, et al
    Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast Cancer.
    Clin Breast Cancer. 2017 Dec 27. pii: S1526-8209(17)30624.
    >> Share

  437. MORIKAWA A, Wang R, Patil S, Diab A, et al
    Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection.
    Clin Breast Cancer. 2017 Dec 21. pii: S1526-8209(17)30394.
    >> Share

  438. GORNSTEIN EL, Sandefur S, Chung JH, Gay LM, et al
    BRCA2 Reversion Mutation Associated With Acquired Resistance to Olaparib in Estrogen Receptor-positive Breast Cancer Detected by Genomic Profiling of Tissue and Liquid Biopsy.
    Clin Breast Cancer. 2017 Dec 21. pii: S1526-8209(17)30680.
    >> Share

  439. YERUVA SLH, Javadi MS, Stearns V
    Complete Response to Single-agent Palbociclib in Metastatic Breast Cancer: A Case Report.
    Clin Breast Cancer. 2017 Dec 21. pii: S1526-8209(17)30533.
    >> Share

  440. MEISEL J, Zhang C, Neely C, Mendoza P, et al
    Evaluation of Prognosis in Hormone Receptor-Positive/HER2-Negative and Lymph Node-Negative Breast Cancer With Low Oncotype DX Recurrence Score.
    Clin Breast Cancer. 2017 Dec 14. pii: S1526-8209(17)30562.
    >> Share

  441. MOLDERINGS GJ, Knuchel-Clarke R, Hertfelder HJ, Kuhl C, et al
    Mast Cell Activation Syndrome Mimicking Breast Cancer: Case Report With Pathophysiologic Considerations.
    Clin Breast Cancer. 2017 Dec 12. pii: S1526-8209(17)30532.
    >> Share

  442. KUBA S, Maeda S, Matsumoto M, Yamanouchi K, et al
    Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: A Prospective Observational Study in Japanese Women.
    Clin Breast Cancer. 2017 Dec 12. pii: S1526-8209(17)30626.
    >> Share

  443. SHEPPARD VB, de Mendoza AH, He J, Jennings Y, et al
    Initiation of Adjuvant Endocrine Therapy in Black and White Women With Breast Cancer.
    Clin Breast Cancer. 2017 Dec 12. pii: S1526-8209(17)30356.
    >> Share

  444. CHIBA A, Raman R, Thomas A, Lamy PJ, et al
    Serum Vitamin D Levels Affect Pathologic Complete Response in Patients Undergoing Neoadjuvant Systemic Therapy for Operable Breast Cancer.
    Clin Breast Cancer. 2017 Dec 11. pii: S1526-8209(17)30324.
    >> Share

  445. ELGHOROURY EA, ElDine HG, Kamel SA, Abdelrahman AH, et al
    Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.
    Clin Breast Cancer. 2017 Dec 7. pii: S1526-8209(17)30458.
    >> Share

  446. SCIMECA M, Antonacci C, Toschi N, Giannini E, et al
    Breast Osteoblast-like Cells: A Reliable Early Marker for Bone Metastases From Breast Cancer.
    Clin Breast Cancer. 2017 Dec 5. pii: S1526-8209(17)30209.
    >> Share

    November 2017
  447. BASTIAANNET E, Charman J, Johannesen TB, Schrodi S, et al
    A European, Observational Study of Endocrine Therapy Administration in Patients With an Initial Diagnosis of Hormone Receptor-Positive Advanced Breast Cancer.
    Clin Breast Cancer. 2017 Nov 29. pii: S1526-8209(17)30728.
    >> Share

  448. LANDMAN Y, Ilouze M, Wein S, Neiman V, et al
    Rapid Response to Larotrectinib (LOXO-101) in an Adult Chemotherapy-Naive Patients With Advanced Triple-Negative Secretory Breast Cancer Expressing ETV6-NTRK3 Fusion.
    Clin Breast Cancer. 2017 Nov 28. pii: S1526-8209(17)30561.
    >> Share

  449. HAMELINCK VC, Bastiaannet E, Pieterse AH, van de Velde CJH, et al
    Preferred and Perceived Participation of Younger and Older Patients in Decision Making About Treatment for Early Breast Cancer: A Prospective Study.
    Clin Breast Cancer. 2017 Nov 28. pii: S1526-8209(17)30409.
    >> Share

  450. RASOOL I, Afroze D, Wani KA, Yousuf A, et al
    Role of the Functional Polymorphism of Survivin Gene (-31G/C) and Risk of Breast Cancer in a North Indian Population.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30631.
    >> Share

  451. FURRER D, Jacob S, Michaud A, Provencher L, et al
    Association of Tobacco Use, Alcohol Consumption and HER2 Polymorphisms With Response to Trastuzumab in HER2-Positive Breast Cancer Patients.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30318.
    >> Share

  452. FLEMING CA, McCarthy K, Ryan C, McCarthy A, et al
    Evaluation of Discordance in Primary Tumor and Lymph Node Response After Neoadjuvant Therapy in Breast Cancer.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30679.
    >> Share

  453. CHANG HT, Pan HJ, Lee CH
    Prevention of Tamoxifen-related Nonalcoholic Fatty Liver Disease in Breast Cancer Patients.
    Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30357.
    >> Share

  454. KIM JY, Jung EJ, Park HJ, Lee JH, et al
    Tumor-Suppressing Effect of Silencing of Annexin A3 Expression in Breast Cancer.
    Clin Breast Cancer. 2017 Nov 21. pii: S1526-8209(17)30504.
    >> Share

  455. INOUE Y, Yamashita N, Kitao H, Tanaka K, et al
    Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer.
    Clin Breast Cancer. 2017 Nov 21. pii: S1526-8209(17)30385.
    >> Share

  456. GRANDI G, Toss A, Cagnacci A, Marcheselli L, et al
    Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History.
    Clin Breast Cancer. 2017 Nov 14. pii: S1526-8209(17)30488.
    >> Share

  457. CHKHEIDZE R, Sanders MAG, Haley B, Leitch AM, et al
    Isolated Contralateral Axillary Lymph Node Involvement in Breast Cancer Represents a Locally Advanced Disease Not Distant Metastases.
    Clin Breast Cancer. 2017 Nov 10. pii: S1526-8209(17)30456.
    >> Share

  458. KARAKAS Y, Dizdar O, Aksoy S, Hayran M, et al
    The Effect of Total Size of Lesions in Multifocal/Multicentric Breast Cancer on Survival.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30449.
    >> Share

  459. HOU Y, Nitta H, Wei L, Banks PM, et al
    Evaluation of Immune Reaction and PD-L1 Expression Using Multiplex Immunohistochemistry in HER2-Positive Breast Cancer: The Association With Response to Anti-HER2 Neoadjuvant Therapy.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30604.
    >> Share

  460. RAGHAVENDRA A, Sinha AK, Valle J, Shen Y, et al
    Determinants of Weight Gain During Adjuvant Endocrine Therapy and Association of Such Weight Gain With Recurrence in Long-term Breast Cancer Survivors.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30621.
    >> Share

  461. FIGUEIREDO FWDS, Adami F
    Income Inequality and Mortality Owing to Breast Cancer: Evidence From Brazil.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30526.
    >> Share

  462. WADASADAWALA T, Lewis S, Parmar V, Budrukkar A, et al
    Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population.
    Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30383.
    >> Share

  463. FISCHER A, Ziogas A, Anton-Culver H
    Negative Valence Life Events Promote Breast Cancer Development.
    Clin Breast Cancer. 2017 Nov 1. pii: S1526-8209(16)30501.
    >> Share

    October 2017
  464. MCREE AJ, Marcom PK, Moore DT, Zamboni WC, et al
    A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer.
    Clin Breast Cancer. 2017 Oct 28. pii: S1526-8209(17)30313.
    >> Share

  465. MCVEIGH TP, Wiggins J, Ward S, Kemp Z, et al
    Successful Repatriation of Breast Cancer Surveillance for High-Risk Women to the UK National Health Service Breast Screening Programme.
    Clin Breast Cancer. 2017 Oct 28. pii: S1526-8209(17)30489.
    >> Share

  466. PROCHOWSKI IAMURRI A, Ponziani M, Macchini M, Fogante M, et al
    Evaluation of Multifocality and Multicentricity With Breast Magnetic Resonance Imaging in Each Breast Cancer Subtype.
    Clin Breast Cancer. 2017 Oct 28. pii: S1526-8209(17)30164.
    >> Share

  467. SALOUSTROS E, Nikolaou M, Kalbakis K, Polyzos A, et al
    Weekly Paclitaxel and Carboplatin Plus Bevacizumab as First-Line Treatment of Metastatic Triple-Negative Breast Cancer. A Multicenter Phase II Trial by the Hellenic Oncology Research Group.
    Clin Breast Cancer. 2017 Oct 24. pii: S1526-8209(17)30153.
    >> Share

  468. HARDEFELDT PJ, Penninkilampi R, Edirimanne S, Eslick GD, et al
    Physical Activity and Weight Loss Reduce the Risk of Breast Cancer: A Meta-analysis of 139 Prospective and Retrospective Studies.
    Clin Breast Cancer. 2017 Oct 17. pii: S1526-8209(16)30429.
    >> Share

  469. KUROSKY SK, Mitra D, Zanotti G, Kaye JA, et al
    Treatment Patterns and Outcomes of Patients With Metastatic ER(+)/HER-2(-) Breast Cancer: A Multicountry Retrospective Medical Record Review.
    Clin Breast Cancer. 2017 Oct 14. pii: S1526-8209(17)30060.
    >> Share

  470. CHANG AE, Wu QV, Jenkins IC, Specht JM, et al
    Phase I/II Trial of Combined Pegylated Liposomal Doxorubicin and Cyclophosphamide in Metastatic Breast Cancer.
    Clin Breast Cancer. 2017 Oct 9. pii: S1526-8209(17)30280.
    >> Share

  471. JANDIAL R, Hoshide R, Waters JD, Somlo G, et al
    Operative and Therapeutic Advancements in Breast Cancer Metastases to the Brain.
    Clin Breast Cancer. 2017 Oct 7. pii: S1526-8209(17)30417.
    >> Share

  472. HIEKEN TJ, Murphy BL, Boughey JC, Degnim AC, et al
    Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes.
    Clin Breast Cancer. 2017 Oct 7. pii: S1526-8209(17)30370.
    >> Share

  473. RAISS H, Peron J, Tartas S, Trillet-Lenoir V, et al
    Palbociclib-Induced Thrombotic Microangiopathy in Metastatic Breast Cancer Patient Surviving for 18 Years: Case Report and Review of the Literature.
    Clin Breast Cancer. 2017 Oct 7. pii: S1526-8209(17)30072.
    >> Share

  474. HAYASHI N, Takahashi Y, Matsuda N, Tsunoda H, et al
    The Prognostic Effect of Changes in Tumor Stage and Nodal Status After Neoadjuvant Chemotherapy in Each Primary Breast Cancer Subtype.
    Clin Breast Cancer. 2017 Oct 3. pii: S1526-8209(17)30319.
    >> Share

    September 2017
  475. HOUSSAMI N
    Evidence on Synthesized Two-dimensional Mammography Versus Digital Mammography When Using Tomosynthesis (Three-dimensional Mammography) for Population Breast Cancer Screening.
    Clin Breast Cancer. 2017 Sep 28. pii: S1526-8209(17)30558.
    >> Share

  476. HEGDE JV, Wang X, Attai DJ, DiNome ML, et al
    Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
    Clin Breast Cancer. 2017 Sep 27. pii: S1526-8209(17)30512.
    >> Share

  477. ITO T, Oura S, Nagamine S, Takahashi M, et al
    Radiofrequency Ablation of Breast Cancer: A Retrospective Study.
    Clin Breast Cancer. 2017 Sep 25. pii: S1526-8209(17)30241.
    >> Share

  478. LEAL AD, Van Houten H, Sangaralingham L, Freedman RA, et al
    Breast Cancer Survivorship Care Variations Between Adjuvant Chemotherapy Regimens.
    Clin Breast Cancer. 2017 Sep 22. pii: S1526-8209(17)30422.
    >> Share

  479. AKIMOTO E, Kadoya T, Kajitani K, Emi A, et al
    Role of 18F-PET/CT in Predicting Prognosis of Patients With Breast Cancer After Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30037.
    >> Share

  480. WU J, Wang S, Liu F, Li S, et al
    Single Nucleotide Polymorphisms in the Acylphosphatase 2 Gene and The SNP-SNP Interactions on the Risk of Breast Cancer in Chinese Han Women.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30157.
    >> Share

  481. DIANATINASAB M, Mohammadianpanah M, Daneshi N, Zare-Bandamiri M, et al
    Socioeconomic Factors, Health Behavior, and Late-Stage Diagnosis of Breast Cancer: Considering the Impact of Delay in Diagnosis.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30358.
    >> Share

  482. MANN JM, Wu X, Christos P, Nagar H, et al
    The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30461.
    >> Share

  483. SAFRA T, Kaufman B, Kadouri L, Efrat Ben-Baruch N, et al
    Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2- Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30180.
    >> Share

  484. SPINELLI VARELLA MA, Teixeira da Cruz J, Rauber A, Varella IS, et al
    Role of BI-RADS Ultrasound Subcategories 4A to 4C in Predicting Breast Cancer.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(16)30505.
    >> Share

  485. OBERGUGGENBERGER A, Meraner V, Sztankay M, Hilbert A, et al
    Health Behavior and Quality of Life Outcome in Breast Cancer Survivors: Prevalence Rates and Predictors.
    Clin Breast Cancer. 2017 Sep 18. pii: S1526-8209(17)30454.
    >> Share

  486. FERNANDEZ-GONZALEZ S, Falo C, Pla MJ, Pernas S, et al
    The Shift From Sentinel Lymph Node Biopsy Performed Either Before or After Neoadjuvant Systemic Therapy in the Clinical Negative Nodes of Breast Cancer Patients. Results, and the Advantages and Disadvantages of Both Procedures.
    Clin Breast Cancer. 2017 Sep 4. pii: S1526-8209(17)30565.
    >> Share

  487. ANAMPA J, Chen A, Wright J, Patel M, et al
    Phase I Trial of Veliparib, a Poly ADP Ribose Polymerase Inhibitor, Plus Metronomic Cyclophosphamide in Metastatic HER2-negative Breast Cancer.
    Clin Breast Cancer. 2017 Sep 1. pii: S1526-8209(17)30468.
    >> Share

  488. ROGOZ B, Houze de l'Aulnoit A, Duhamel A, Houze de l'Aulnoit D, et al
    Thirty-Year Trends of Survival and Time-Varying Effects of Prognostic Factors in Patients With Metastatic Breast Cancer-A Single Institution Experience.
    Clin Breast Cancer. 2017 Sep 1. pii: S1526-8209(16)30427.
    >> Share

    August 2017
  489. CHAMP CE, Ohri N, Klement RJ, Cantor M, et al
    Assessing Changes in the Activity Levels of Breast Cancer Patients During Radiation Therapy.
    Clin Breast Cancer. 2017 Aug 24. pii: S1526-8209(17)30285.
    >> Share

  490. CHAO YL, Anders CK
    TYMS Gene Polymorphisms in Breast Cancer Patients Receiving 5-Fluorouracil-Based Chemotherapy.
    Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30369.
    >> Share

  491. WANG Y, Brodsky AS, Xiong J, Lopresti ML, et al
    Stromal Clusterin Expression Predicts Therapeutic Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer.
    Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30349.
    >> Share

  492. CID S, Eiro N, Fernandez B, Sanchez R, et al
    Prognostic Influence of Tumor Stroma on Breast Cancer Subtypes.
    Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30189.
    >> Share

  493. CHOI WJ, Kim WK, Shin HJ, Cha JH, et al
    Evaluation of the Tumor Response After Neoadjuvant Chemotherapy in Breast Cancer Patients: Correlation Between Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathologic Tumor Cellularity.
    Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30058.
    >> Share

  494. AZIM HA, Abdel-Malek R, Kassem L
    Predicting Brain Metastasis in Breast Cancer Patients: Stage Versus Biology.
    Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30235.
    >> Share

  495. KOOL M, Bastiaannet E, Van de Velde CJH, Marang-van de Mheen PJ, et al
    Reliability of Self-reported Treatment Data by Patients With Breast Cancer Compared With Medical Record Data.
    Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30212.
    >> Share

  496. DONG H, Huang Y, Song F, Dai H, et al
    Improved Performance of Adjunctive Ultrasonography After Mammography Screening for Breast Cancer Among Chinese Females.
    Clin Breast Cancer. 2017 Aug 15. pii: S1526-8209(17)30321.
    >> Share

  497. CHEN W, Huang Y, Lewis GD, Szeja SS, et al
    Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based Study.
    Clin Breast Cancer. 2017 Aug 10. pii: S1526-8209(17)30185.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016